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Chapter 1  
Introduction 
 
Technological innovation in the past decade has dramatically increased the amount and 
variety of genomic data available to geneticists. While it took over a decade to sequence the 
first human genome, a new sample today can be sequenced in a few hours according the 
product manuals for “next-generation” sequencing (NGS) technologies. Additionally, array-
based genotyping methods can assay millions variants in a matter of minutes. With faster data 
generation, we also see lower unit costs. The long awaited $1000 genome is finally within 
reach. These advances have enabled large-scale genomic studies that would have been 
impossible just a few years ago. 
While high-throughput technologies have increased the number of samples that can be 
analyzed, they have also increased the opportunities for errors to occur. Even if per-experiment 
errors are relatively rare, the large number of experiments performed means it is likely errors 
will occur. Imperfect methods and protocols may result in systematic biases or errors in the 
generated data. If ignored, these errors may result in inaccurate genotypes which could lead to 
false associations between genotypes and a trait of interest or reduced power to detect such 
associations. For this reason, proper quality assessment is an important part of any data 
processing pipeline. If possible, test for errors should be easy to execute and interpret in an 
automated way as early in the experimental pipeline as possible. 
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One potential source of inaccurate genomic data is sample contamination. We define 
contamination as the accidental mixture of DNA or RNA from two or more individuals from the 
same species. Contamination between different species is also possible1,2, but we will focus on 
the more challenging problem of contamination among human samples. Throughout the course 
of a study, physical samples may be handled and manipulated in the laboratory and it is 
possible for two DNA or RNA samples to become mixed. Anytime samples are pipetted (e.g. 
during collection, storage, or extraction) there is an opportunity for contamination. Improper 
shipment of samples in well plates from a repository to a processing center may also result in 
contamination. Additionally, some protocols require forms of PCR amplification and if multiple, 
barcoded samples are processed together, there is a risk of amplification errors that may result 
in a portion of the DNA being paired with the wrong barcode. One final example involves 
improper data merging. Some protocols sequence samples across many batches and then 
combine the data before processing. Even if all sequenced samples were uncontaminated, 
incorrect data merging may result in a data file that appears to be contaminated. 
There is a need for methods to detect sample contamination for both array-based and 
sequencing-based data. For array-based genotypes, samples are often filtered or excluded 
based on the number of missing genotypes. It is possible that the cause of missing genotypes is 
contamination.  However there are other possible causes as well and no attempt has been 
made to test or quantify contamination specifically for array-based genotypes. For sequencing 
data, there are methods that look at cross-species contamination by filtering out sequence 
during alignment3, and there is a Bayesian method that additionally requires you to know the 
true genotypes (presumably from an array-based method)4. Because contamination increases 
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the diversity of alleles observed at a particular variant site, contaminated samples will generally 
have more heterozygous genotypes than expected for uncontaminated samples. Filtering 
individuals with a large number of heterozygous SNPs is a useful quality filter but it does not 
help quantify contamination and it also requires prior running of a genotype caller on the 
sample, an additional time-consuming step which could mean delays on the order of months 
before contamination is detected, allowing a contamination-prone process to continue. 
In this thesis, I propose a comprehensive set of tools for dealing with contamination in 
modern genetic data. In chapter 2, I will look at detecting and quantifying contamination in 
both array-based genotyping data and NGS data. In chapter 3, I focus specifically on NGS data 
and propose a novel genotype calling algorithm that can produce accurate genotypes even 
when samples are contaminated. In chapter 4, I extend the methods for contamination 
detection to RNA sequencing (RNA-Seq) data. Finally in chapter 5, I reflect on the usefulness of 
these methods and describe possible future extensions.  
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Chapter 2  
Detecting and estimating contamination of human DNA samples in 
sequencing and array-based genotype data 
 
AbstractA 
DNA sample contamination is a serious problem in DNA sequencing studies, and may 
result in systematic genotype misclassification and false positive associations.  While methods 
exist to detect and filter out cross-species contamination, few methods to detect within-species 
sample contamination are available.  In this paper, we describe methods to identify within-
species DNA sample contamination based on (1) a combination of sequencing reads and array-
based genotype data; (2) sequence reads alone; and (3) array-based genotype data alone.  
Analysis of sequencing reads allows contamination detection after sequence data is generated 
but prior to variant calling; analysis of array-based genotype data allows contamination 
detection prior to generation of costly sequence data.  Through a combination of analysis of in-
silico and experimentally contaminated samples, we show that our methods can reliably detect 
and estimate levels of contamination as low as 1%.  We evaluate the impact of DNA 
contamination on genotype accuracy, and propose effective strategies to screen for and 
prevent DNA contamination in sequencing studies. 
                                                     
A This work has been published: Jun, G., Flickinger, M., Hetrick, K.N., Romm, J.M., Doheny, K.F., Abecasis, G.R., 
Boehnke, M., Kang, H.M. (2012). Detecting and estimating contamination of human DNA samples in sequencing 
and array-based genotype data. Am J Hum Genet 91, 839–848. 
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Introduction 
Advances in array-based genotyping and next-generation sequencing have resulted in 
higher throughput, lower costs, and reduced error rates.  These technologies enable 
increasingly comprehensive genetic studies for a wide range of human diseases and traits.  
While constantly improving, genotyping and sequencing technologies are not perfect, and 
careful attention must be paid to ensure high data quality.  Sensitive and efficient methods to 
screen data for potential artifacts are critical. 
One potential source of error is DNA sample contamination.  Because samples are often 
processed in batches and genotyping and sequencing protocols require multiple steps of 
sample handling and manipulation in the lab, it is not surprising that DNA from more than one 
individual may end up in the same well or prepared library.  In this paper, we focus on within-
species contamination in which DNA from more than one individual is present, either from 
another individual in the same study or from an unknown individual.  Note that cross-species 
contamination can often be detected and filtered out during the alignment of sequence reads1. 
Within species contamination is harder to detect, and can result in greatly reduced genotype 
quality for sequencing studies; the problem is most severe for low pass sequencing studies 
(where each allele is typically supported by only a few reads), but can affect even deep 
sequencing studies. 
In a recent type 2 diabetes sequencing study, we identified a subset of individuals with 
unusually large numbers of heterozygous genotypes and high ratios of heterozygous genotypes 
to non-reference allele homozygous genotypes (HET/HOM ratio) (Figure 2-1AB).  We 
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hypothesized that some DNA samples might be contaminated, resulting in poor genotype 
estimates and inflated heterozygosity and, therefore, set about to develop methods to identify 
such contamination and estimate its extent. 
 
Here, we describe methods to detect DNA sample contamination based on sequencing 
and/or array-based genotype data.  We demonstrate that when sequencing is carried out on 
DNA samples for which array-based genotypes are available, it is possible to estimate the level 
of sample contamination, and to identify the source of the contamination (see Web 
Resources)2.  We further demonstrate that even with low-pass sequencing data alone, we can 
detect and estimate the degree of contamination.  Finally, and perhaps most important, we 
demonstrate that it is possible to detect even modest levels of DNA sample contamination from 
array-based genotype data alone, allowing DNA samples to be pre-screened for possible 
Figure 2-1 - SNP genotype calling and estimation of 
contamination from 299 European sequenced samples:  
chromosome 20 - A. Numbers of heterozygous genotypes.  B. 
Ratio of the numbers of non-reference homozygous genotypes to 
heterozygous genotypes (HET/HOM ratio).  C. Estimated level of 
DNA sample contamination estimated from sequence data only. 
8 
 
contamination prior to sequencing.  Software based on our methods is already in use by major 
sequencing projects, including the 1000 Genomes Project, and is publicly available (see Web 
Resources). 
Materials and Methods 
In this section, we first describe a series of methods to evaluate DNA sample 
contamination and then outline a series of experiments carried out to evaluate our ability to 
identify contaminated samples.  We present three likelihood-based methods that detect DNA 
sample contamination using (a) sequence data and array-based genotype data, (b) sequence 
data alone, and (c) array-based genotype data alone.  We also present a regression-based 
method that uses array-based genotype data alone.  For each of these methods, we assume 
that if DNA from a “contaminating sample” represents a fraction 𝛼 of the observed data, then 
the same fraction 𝛼 of sequence reads and genotype array intensity will be contributed by the 
contaminating sample.  Initially, we also assume the presence of no more than one 
contaminating DNA sample (but see Discussion). 
Detecting sample contamination using sequence data and array-based genotype data jointly 
We first consider the simplest situation where a set of genotypes for each sequenced 
sample is known and we wish to investigate whether sequencing reads all originate from the 
targeted sample with no evidence for contaminating reads from a different sample.  For each 
site  , let 𝑔𝑖 be the true genotype, 𝑏𝑖𝑗 (1 ≤ 𝑗 ≤ 𝑅𝑖) be the base call for the 𝑗
th overlapping base 
(among 𝑅𝑖 total reads overlapping site i and passing mapping and base quality thresholds), and 
𝑒𝑖𝑗 be a latent indicator variable that takes value 0 when 𝑏𝑖𝑗 is called correctly and 1 otherwise.  
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Assuming that sequencing errors are equally likely to result in any of the three alternate bases, 
the conditional probabilities of observing a specific overlapping base given the true genotype 
and error status 𝑃(𝑏𝑖𝑗|𝑔𝑖, 𝑒𝑖𝑗 ) can be calculated easily (Table 2-1).  The conditional likelihood of 
a single overlapping base can then be written as the two-sample mixture model  
𝑃(𝑏𝑖𝑗|𝑔𝑖
1, 𝑔𝑖
2, 𝑒𝑖𝑗; 𝛼) = (1 − 𝛼)𝑃(𝑏𝑖𝑗|𝑔𝑖
1, 𝑒𝑖𝑗) + 𝛼𝑃(𝑏𝑖𝑗|𝑔𝑖
2, 𝑒𝑖𝑗) 
where 𝑔𝑖
1 and 𝑔𝑖
2 are the genotypes of the targeted and contaminating DNA samples at site 𝑖 
and 𝛼 is the sample contamination level.  Note that, in this section, we assume array based 
genotypes are error-free and therefore 𝑔𝑖
1 is known.  In later sections, our methods that use 
either sequence or array-based data alone remove this restriction. 
True Genotype gi 
Base Calling  
Error Event eij 
Pr(bij = A) Pr(bij = B) Pr(bij = E)  
gi = AA 
eij = 0 1 0 0 
eij = 1 0 1/3 2/3 
gi = AB 
eij = 0 1/2 ½ 0 
eij = 1 1/6 1/6 2/3 
gi = BB 
eij = 0 0 1 0 
eij = 1 1/3 0 2/3 
Table 2-1 Conditional probability 𝑃(𝑏𝑖𝑗  | 𝑒𝑖𝑗, 𝑔𝑖) of read 𝑏𝑖𝑗 given true genotype 𝑔𝑖 and read 
error 𝑒𝑖𝑗. ( AA: A allele homozygote, AB: heterozygote, BB: B allele homozygote, E: alleles other 
than A or B) 
In the absence of knowledge of the identity of the contaminating individual, we 
formulate the likelihood  
ℒ(𝛼) = ∏ ∑ ∑ ∑ {∏ ∑ 𝑃(𝑏𝑖𝑗|𝑔𝑖
1, 𝑔𝑖
2, 𝑒𝑖𝑗, 𝜀𝑖; 𝛼)𝑃(𝑒𝑖𝑗)𝑒𝑖𝑗
𝑅𝑖
𝑗=1 } 𝑃(𝑔𝑖
2)𝑔𝑖
2 𝑃(𝑔𝑖
1|𝜀𝑖; 𝐺𝑖)𝑔𝑖
1 𝑃(𝜀𝑖)𝜀𝑖
𝑀
𝑖=1   
(Eqn 1) 
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Here, 𝑀 is the number of genotyped sites for the targeted individual, 𝐺𝑖 is the array-based 
genotype for the targeted individual at site 𝑖, and 𝜀𝑖 is a binary indicator of genotyping error 
events.  In Equation 1, we calculate genotype probabilities 𝑃(𝑔𝑖
2) from population allele 
frequency estimates assuming Hardy-Weinberg equilibrium, and error probabilities 
𝑃(𝑒𝑖𝑗 = 1) = 10
−𝑄𝑖𝑗/10 and 𝑃(𝑒𝑖𝑗 = 0) = 1 − 10
−𝑄𝑖𝑗/10, where 𝑄𝑖𝑗 is the phred-scale base 
quality score.  For simplicity, we assume 𝑃(𝑔𝑖
1 = 𝐺𝑖|𝜀 = 0; 𝐺𝑖) = 1 
and 𝑃(𝑔𝑖
1 = (𝐺 ≠ 𝐺𝑖)|𝜀 = 1; 𝐺𝑖) = 0.5. We estimate the contamination fraction 𝛼 by 
maximizing the likelihood in Equation 1, first using a grid search on the interval [0, 1], and then 
applying Brent’s algorithm3.     
To identify the contaminating individual among the 𝑁 study individuals with array-based 
genotype data, we consider the likelihood function 
ℒ(𝛼, 𝑘) = ∏ ∑ ∑ ∑ ∑ {∏ ∑ 𝑃(𝑏𝑖𝑗|𝑔𝑖
1, 𝑔𝑖
𝑘 , 𝑒𝑖𝑗, 𝜀𝑖
1, 𝜀𝑖
𝑘; 𝛼)𝑃(𝑒𝑖𝑗)
𝑒𝑖𝑗
𝑅𝑖
𝑗=1
}
𝑔𝑖
𝑘
𝑃(𝑔𝑖
1|𝜀𝑖
1; 𝐺𝑖)𝑃(𝑔𝑖
𝑘|𝜀𝑖
𝑘; 𝐺𝑖)
𝑔𝑖
1
𝑃(𝜀𝑖
1)𝑃(𝜀𝑖
𝑘)
𝜀𝑖
𝑘𝜀𝑖
1
𝑀
𝑖=1
 
for individuals 2 ≤ 𝑘 ≤ 𝑁.  Using maximum likelihood across 𝛼 and 𝑘, we estimate the most 
likely contaminating individual 𝑘 and contamination level 𝛼.  By comparing the maximum 
likelihoods (over 𝛼) for the most likely and next most likely contaminating samples, including 
the generic individual represented by population allele frequencies (as in Equation 1), we 
obtain a measure of support for the inferred contaminating individual.  
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Detecting sample contamination using sequence data alone 
Next, we consider the problem of identifying contamination when prior genotype data 
are not available. In the absence of prior genotype data, both 𝑔𝑖1 and 𝑔𝑖
2 are unknown, and the 
likelihood for the contamination level 𝛼 becomes 
ℒ(𝛼) = ∏ ∑ ∑ {∏ ∑ ((1 − 𝛼)𝑃(𝑏𝑖𝑗|𝑔𝑖
1, 𝑒𝑖𝑗) +  𝛼𝑃(𝑏𝑖𝑗|𝑔𝑖
2, 𝑒𝑖𝑗)) 𝑃(𝑒𝑖𝑗)𝑒𝑖𝑗
𝑅𝑖
𝑗=1 } 𝑃(𝑔𝑖
2)𝑃(𝑔𝑖
1)𝑔𝑖
2𝑔𝑖
1
𝑀
𝑖=1       (Eqn 2)  
Equation 2 can be maximized using an initial grid search followed by Brent’s algorithm.  In 
contrast to Equation 1 in which array-based genotype data are available, Equation 2 is 
symmetric with respect to the targeted and contaminating individuals.  In this situation, with 
sequence data alone and without previously known genotypes, our method cannot detect 
sample swaps.  Further, since 𝐿(𝛼) = 𝐿(1 − 𝛼), here we restrict attention to 0 ≤ 𝛼 ≤ ½. 
Detecting sample contamination using array-based genotype data alone 
We next turn to the problem of detecting DNA sample contamination using array-based 
genotype data alone, an analysis which can be carried out to identify contaminated samples 
prior to sequencing.  We assume the availability of relative intensity information, as produced 
for example by the Illumina Infinium assay.  The Infinium assay measures the relative intensities 
of fluorescently labeled probes associated with arbitrarily labeled alleles A and B.  After 
normalizing intensities, the Illumina software reports (1) the genotype as AA, AB, BB, assigning 
a missing genotype to individuals with intensities outside the expected clusters; and (2) the 
estimated abundance of the B allele, called the B allele frequency (BAF).  We expect BAF close 
to 0, ½, or 1 for genotypes AA, AB, and BB, respectively.  We describe two types of 
contamination detection and estimation methods in this setting:  two likelihood-based mixture-
12 
 
model methods based on the intensity values, and a regression-based method using BAF as 
input. 
Detecting sample contamination using array data alone:  mixture models for intensity data 
We implement our mixture model on the genotype intensity data in two ways.  One 
implementation estimates model parameters by examining signal intensity distributions for 
each marker across all samples; a second implementation estimates signal intensity 
distributions by examining all markers for a single sample.  Both implementations use genotype 
intensity values normalized by the GenomeStudio software as input, to reduce technical 
differences across samples and markers. 
In the multi-sample implementation, for each marker 𝑖, we model the normalized A and 
B allele intensity data 𝒙𝒊 = (𝑥,𝐴 𝑥𝐵) for an uncontaminated DNA sample as a bivariate Gaussian 
distribution:  
 𝑝𝑖(𝐱𝒊|𝑔𝒊)~𝒩(𝝁𝒊
𝒈𝒊 , 𝚺𝒊
𝒈𝒊),    𝑔𝒊 = {𝐴𝐴, 𝐴𝐵, 𝐵𝐵}, 1 ≤ 𝑖 ≤ 𝑀 
Here, 𝑔𝒊 is again the true genotype at marker 𝑖, 𝝁𝒊
𝒈𝒊  is the intensity mean vector for marker 𝑖 
given 𝑔𝑖, and 𝚺𝒊
𝒈𝒊  is the covariance matrix of the A and B allele intensities.  We estimate 𝝁𝒊
𝒈𝒊  
and 𝚺𝒊
𝒈𝒊  using observed signal intensities and called genotypes at marker i across all genotyped 
individuals.  To reduce the impact of genotype misclassification, we exclude samples with call 
rate < 99% and markers with minor allele frequency < 1%.  Assuming the observed DNA sample 
is a mixture of two unrelated DNA samples, we can model the intensity values as a bivariate 
Gaussian mixture: 
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𝑝𝑖(𝐱𝒊|𝑔𝑖
1, 𝑔𝑖
2; 𝛼)~𝒩 (𝛼𝝁𝒊
𝑔𝑖
1
+ 𝛼𝝁𝒊
𝑔𝑖
2
, 𝛼2𝚺𝒊
𝑔𝑖
1
+ (𝟏 − 𝛼)2𝚺𝒊
𝑔𝑖
2
)     1 ≤ 𝑖 ≤ 𝑀 
where 𝑔𝑖
1 and 𝑔𝑖
2 are the genotypes of the two samples at marker 𝑖.  Given data on 𝑀 
independent markers, we formulate the likelihood of a sample using the intensity distribution 
estimated across multiple samples as 
ℒ(𝛼) = ∏ ∑ ∑ 𝑝𝑖(𝐱𝒊|𝑔𝑖
1, 𝑔𝑖
2)𝑃(𝑔𝑖
1)𝑃(𝑔𝑖
2)𝑔𝑖
2𝑔𝑖
1
𝑀
𝑖=1  (Equation 3) 
Genotype probabilities 𝑃(𝑔𝑖
𝑘) in Equation 3 can be calculated assuming Hardy-Weinberg 
equilibrium using allele frequencies estimated from the called genotypes or from external data.  
As before, we estimate 𝛼 by maximum likelihood using a grid search on the interval [0, ½] 
followed by Brent’s algorithm.  With genotype array data alone, we cannot detect sample 
swaps.   
The single-sample implementation is analogous to the multi-sample implementation.  In 
the multi-sample implementation, the bivariate Gaussian parameters for 𝑝𝑖 at each marker are 
estimated across all 𝑁 samples, while in the single-sample implementation, parameters for 𝑝𝑘 
are estimated across all 𝑀 markers called in the individual.  The corresponding likelihood of 
single-sample implementation follows 
ℒ(𝛼) = ∏ ∑ ∑ 𝑝𝑘(𝒙𝒊|𝑔𝑖
1, 𝑔𝑖
2)𝑃(𝑔𝑖
1)𝑃(𝑔𝑖
2)
𝑔𝑖
2𝑔𝑖
1
𝑀
𝑖=1
 
where 𝑝𝑘(𝒙|𝑔𝑖
1, 𝑔𝑖
2) is mixture of bivariate Gaussians whose parameters are estimated across 
all markers for individual 𝑘.  
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The multi-sample implementation is appropriate when many samples have been 
genotyped and can be used to estimate the distribution of signal intensities for each marker.  
The single-sample implementation can be used when data are available on only one or a few 
samples.  
Detecting sample contamination using array data alone:  regression-based method 
Our second genotype-array-based method detects contamination by identifying 
systematic shifts between the expected and observed BAF in sites called as homozygous.  
Consider an individual with genotype AA whose DNA sample is contaminated.  As the 
population frequency of the B allele increases, the sample is increasingly likely to be 
contaminated with the B allele (Figure 2-2).  In the case of no contamination, we expect BAF 
values close to 0, ½, and 1 for genotypes AA, AB, and BB, respectively.  In the presence of 
contamination, we expect for AA and BB homozygotes that 
𝐸[𝐵𝐴𝐹 | 𝑔 = 𝐴𝐴; 𝛼, 𝑝𝐵] = 𝛼𝑝𝐵 
𝐸[𝐵𝐴𝐹 | 𝑔 = 𝐵𝐵; 𝛼, 𝑝𝐴] = 1 − 𝛼𝑝𝐴 
where 𝑝𝐴 and 𝑝𝐵 are the population frequencies of A and B and 𝛼 is again the contamination 
level.  To estimate contamination, we fit the linear regression model 
𝐵𝐴𝐹 = 𝛾 + 𝛼𝑝 + 𝜏𝐼(𝑔 = 𝐴𝐴) +  𝜀  (Equation 4) 
where 𝛾 is the intercept, 
𝑝 = {
𝑝𝐵, if  𝑔 = 𝐴𝐴
−𝑝𝐴, if  𝑔 = 𝐵𝐵
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𝜏 is the difference in expected BAF between AA and BB genotypes, and 𝜀 is a normally 
distributed error term.  This regression framework allows us to estimate the contamination 
level α and to test for contamination by evaluating the null hypothesis that the slope 𝛼 = 0 
against the one-sided alternative 𝛼 > 0.  
 
Figure 2-2 - B allele frequency (BAF) versus population minor allele frequency (MAF) (A) 
uncontaminated (=0) and (B) contaminated (=10%) samples.  Normalized intensity plots for 
(C) uncontaminated (=0) and (D) contaminated (=10%) samples. 
Instead of using the A or B allele frequency as covariate in the regression, we instead 
use the population minor allele frequency (MAF).  This avoids the need to convert Illumina A/B 
allele calls to actual A/G/C/T alleles.  Letting 𝑓 be the MAF 
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Pr(𝐵 is minor allele|𝑔 = 𝐴𝐴; 𝑓)
=
Pr(𝐵 is minor allele, 𝑔 = 𝐴𝐴; 𝑓)
Pr(𝐵 is minor allele, 𝑔 = 𝐴𝐴; 𝑓) + Pr(𝐴 is minor allele, 𝑔 = 𝐴𝐴; 𝑓)
 
                                                            =
(1 − 𝑓)2
(1 − 𝑓)2 + 𝑓2
 
so that 
𝐸[𝐵𝐴𝐹 | 𝑔 = 𝐴𝐴; 𝛼, 𝑓] = 𝛼
𝑓(1 − 𝑓)
(1 − 𝑓)2 + 𝑓2
 
Although the relationship between MAF 𝑓 and contamination level 𝛼 is not linear, we found 
that using a regression model of the form  
𝐵𝐴𝐹 = 𝛾 + 𝛼𝑓 + 𝜏𝐼(𝑔 = 𝐴𝐴) +  𝜀 
produces nearly identical results to using the model in Equation 4 which requires knowledge of 
population allele labels and replaces 𝑓 with 𝑝 (data not shown).  Thus, it is possible to detect 
contamination using only AB genotypes and without decoding the correspondence between 
labels A and B and the underlying A, C, G and T alleles.  This ability to avoid decoding the A and 
B allele labels is important for early steps of data analysis and quality control which, in this way, 
can proceed without worrying about vagaries of specific genome builds and other informatics 
challenges that must be tackled before later rounds of analyses. 
Assumptions 
For ease of computation and notation, our models make several assumptions.  The 
likelihood methods compute likelihoods over multiple markers and/or aligned base positions, 
as simple products of single marker and/or single base call likelihoods.  As written, the resulting 
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likelihoods are strictly correct when sequencing errors are independent at each aligned base 
and markers are in linkage equilibrium; when these assumptions are violated, the likelihoods 
are approximate4.  In practice, violation of these assumptions can be reduced by:  (a) trimming 
overlapping ends of reads generated from the same template before analysis; (b) ensuring that 
variant sites considered in analysis are adequately spaced (so that it is unlikely that multiple 
base calls originating from a single DNA template are used in analysis); and (c) further trimming 
marker lists so they include only markers that are in linkage equilibrium.  In the next section, we 
discuss empirical assessments of our method using real data demonstrating that our methods 
are highly accurate in real data settings. 
Experimental data  
We assessed our contamination estimation and testing methods using in-silico 
contaminated samples and intentionally contaminated real samples.   
To evaluate our sequence-based methods, we constructed in-silico contaminated 
sequence data by randomly mixing aligned sequence reads from 21 CEU individuals sequenced 
at ~4x coverage on an Illumina platform as part of the 1000 Genomes Project.  We retained 
reads from the targeted sample with probability 1 − 𝛼 and from the contaminating sample with 
probability 𝛼 ranging from 0.1% to 50%.  To avoid artifacts from intrinsic contamination of the 
original sequence data, we chose as targeted samples those with estimated contamination ?̂? < 
0.1%.  Because samples had slightly different mean genome coverage and coverage varied 
across each genome, the nine levels of intended contamination 𝛼 actually varied slightly across 
the samples.  For all mixture-model-based methods, we estimated 𝛼 using both joint and 
sequence-only methods.  In both cases, we calculated likelihoods based on sites with MAF > 5% 
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(across 87 CEU samples) assayed on the Illumina HumanOmni2.5 array, using sequence reads 
above phred-scale mapping and base quality thresholds of 13.  We based analyses on the entire 
genome (~1.2M SNPs), chromosome 20 alone (~30K SNPs), or thinned sets of 1,000 to 100,000 
evenly spaced SNPs.  We also estimated 𝛼 using our sequence-only methods based on allele 
frequency estimates from 89 British (GBR), 93 Finnish (FIN), 381 European (CEU, GBR, FIN, TSI, 
IBS), or 246 African (YRI, LWK, ASW) samples to evaluate the impact of errors in estimated SNP 
allele frequencies. 
To evaluate our genotype-array-only methods, we experimentally constructed 
contaminated DNA samples by combining pairs of HapMap CEU individuals and pairs of 
HapMap YRI individuals.  We targeted six contamination levels, ranging from 𝛼 = 0 to 10%.  For 
each contamination level, we targeted three pairs of CEU individuals and three pairs of YRI 
individuals.  We genotyped the 36 resulting samples with the Metabochip, an Illumina genotype 
array that assays ~200,000 SNPs of interest for studies of cardio-metabolic traits5.  We used 
normalized array intensity values, BAF, and genotypes produced by the Illumina’s 
GenomeStudio software run with default options.     
Finally, to evaluate empirically our sequence-based methods, we examined potential 
contamination in 299 actual DNA samples sequenced genome-wide by a large sequencing 
center at ~4x average coverage in a study of type 2 diabetes.  150 samples were sequenced 
before a change in the sample handling process in August 2010; the remaining 149 samples 
were sequenced after the change.  227 of the 299 samples also were genotyped with the 
Illumina HumanOmni2.5 array.  After quality control of the array data, call rates for each 
sample and each SNP were > 98%.  We applied our sequence-based mixture methods to these 
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data across all SNPs with estimated MAF > 5%.  For these samples, we called genotypes from 
the sequence data using glfMultiples6 followed by refinement using BEAGLE7.  From these 
sequence-based genotype data, we calculated the ratio of heterozygous genotypes to 
homozygous non-reference genotypes (HET/HOM ratio) and genotype discordances with the 
HumanOmni2.5 data. All procedures above were approved by the institutional review boards of 
the University of Michigan. 
Results 
Detecting sample contamination using sequence data  
We estimated 𝛼 for the 189 samples constructed with in-silico contamination (0.1% ≤
𝛼 ≤ 50%) based on random pairings of 1000 Genomes Project CEU samples (see Materials and 
Methods).  The estimated contamination level ?̂? conformed well to the intended contamination 
level 𝛼, with Pearson correlation coefficient r = .9996 for the joint method and r = .9840 for the 
sequence-only method (Figure 3).  Both methods tended to overestimate contamination, 
especially when 𝛼 < 1%. Generally, absolute error |?̂? − 𝑎| increased with 𝛼 and relative error 
|?̂? − 𝑎|/𝛼 decreased with 𝛼.  For example, the absolute error was 0.038% ± 0.024% for the 
joint method and 0.037% ± 0.021% for the sequence-only method when 𝛼 ≈ 0.1%, but 
increased  0.41% ± 0.30% and 0.56% ± 0.55% when 𝛼 ≈ 10% (Figure 2-3).  In contrast, the 
relative error of the estimated contamination was .380 ± .257 (mean ± SD) for the joint method 
and .390 ± .241 for the sequence-only method when 𝛼 ≈ 0.1%, but it was reduced to .044 
± .035 and .056 ± .055 when 𝛼 ≈ 10%.  Finally, for the sequence-only method, because ?̂? is 
bounded at 50%, we observed a downward bias for 𝛼 near 50%.   
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Figure 2-3 Estimated contamination levels for in-silico contaminated samples using (A) joint 
sequence and array-based method, (B) sequence-only method, and (C) between these two 
methods. 
We evaluated the impact of estimated population allele frequencies on accuracy of 
contamination estimates (Appendix Figure 2-S1).  Compared to the original sequence-only 
estimates of ?̂? that used CEU allele frequencies, using allele frequencies from the GBR samples 
resulted in reduced estimates of ?̂?  (mean ratio ± SD for ?̂?𝐺𝐵𝑅/?̂?𝐶𝐸𝑈 = .884 ± .083).  Allele 
frequencies from the more distantly related FIN samples resulted in further reduced 
contamination estimates (mean ratio ± SD  for for ?̂?𝐹𝐼𝑁/?̂?𝐶𝐸𝑈 = .804 ± .135).  Allele frequencies 
from the broader European (EUR) continental population (CEU, GBR, FIN, IBS, and TSI) 
performed better (mean ratio ± SD for ?̂?𝐸𝑈𝑅/?̂?𝐶𝐸𝑈 = .926 ± .054), while allele frequencies from 
the very different African (AFR) samples  (YRI, LWK, and ASW) resulted in severe reduction in 
contamination estimates (mean ratio ± SD for ?̂?𝐴𝐹𝑅/?̂?𝐶𝐸𝑈= .160 ± .121).  
Next, we evaluated the impact of the number of sites analyzed on contamination 
estimates using thinned sets of 1,000, 10,000, or 100,000 evenly spaced markers, and using 
only chromosome 20 sites.  These smaller numbers of sites resulted in less accurate estimates 
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of contamination, particularly at lower levels of contamination (Appendix Figure 2-S2).  For 
example, when 𝑎 = 1%, the mean relative errors |?̂? − 𝑎|/𝛼 for the joint method 
were .414, .135, .103, and .099 for 1,000, 10,000, 100,000, and all 1.2M sites, and .112 when 
using the 30,471 chromosome 20 sites.  Since computation times scale linearly with the number 
of sites analyzed, an (initial) analysis based on 10,000 sites or on all chromosome 20 sites 
requires 120- to 40-times less computing effort than an analysis of 1.2M sites.  
We also compared our joint method to ContEst2 (April 2012 version), which uses 
genotype and sequence data together to estimate contamination levels in a likelihood 
framework.  We obtained very similar results for their method and ours when 𝑎 > 1%; when 𝑎  
< 1%, ContEst tended to overestimate contamination levels to a larger degree than ours 
(Appendix Figure 2-S3). 
Estimation and testing of sample contamination from genotype array data only 
Next, we applied our genotype array-only methods to our deliberately constructed 
contaminated samples genotyped with the Metabochip.  Applying the single-sample and multi-
sample mixture model methods produced contamination level estimates that matched our 
constructs, except for two YRI samples with 3% intended contamination (Figure 2-4).  Estimates 
from the regression-based method also showed very strong concordance except for these same 
two samples.  We observe that the two mixture-model methods tend to over-estimate α, while 
the regression-based method tends to underestimate 𝑎. 
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Using the mixture-model methods, 0 of the 6 uncontaminated CEU samples were 
identified as contaminated, while 3 of 6 uncontaminated YRI samples were identified as slightly 
(0 < ?̂? < 1%) contaminated.  We suspect this misclassification is due at least in part to not 
having had Metabochip cluster data for African samples and therefore having used our 
available Finnish samples for defining the clusters used in genotype calling.  The mixture-model 
methods correctly identified 22 of 24 intentionally contaminated samples, the exceptions being 
the two YRI samples with 3% intended contamination.   
Using the regression-based method, we tested the hypothesis of no contamination 
across 24 contaminated and 12 uncontaminated samples at significance level .05/36=.0013; the 
Figure 2-4 Estimated versus intended contamination levels from the experimentally 
contaminated array intensity data, using (A) regression-based method, (B) multi-sample 
mixture model method, and (C) single-sample mixture model method. 
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results correctly identified the contamination state of 34 of the 36 experimental samples except 
for the two YRI samples with intended 𝑎 = 3%.  Given our consistent results across our three 
different methods, we suspect this pair of YRI samples was not successfully contaminated 
during the experimental process.  
We evaluated a modified version of our regression-based method by including data on 
heterozygous sites in addition to homozygous sites or by binning SNPs by MAF; these modified 
approaches performed less well on both simulated and experimental data.  The additional noise 
in the BAF at heterozygous sites made the estimation of contamination less accurate.   
Attempts to smooth out the uneven MAF distribution of SNPs on a genotype array by binning 
and averaging over BAF simply reduced power and failed to improve estimation.  We also 
evaluated the regression method restricting analysis to various MAF bins and observed that the 
method performed best when SNPs across the entire MAF spectrum were included (data not 
shown). 
Type 2 diabetes study  
As described in the Introduction, in a recent sequencing study, early in the study we 
identified a subset of individuals with unusually large numbers of heterozygous genotypes and 
high HET/HOM ratios compared to other sequenced individuals Figure 2-1AB).   We applied our 
sequence-based and sequence-only methods to these samples.  Since HumanOmni2.5 genotype 
data were available on only 227 of these 299 individuals, we display results for the sequence-
only method (Figure 2-1C); contamination level estimates for the sequence and array data 
jointly were very similar, particularly for individuals with higher contamination levels (Figure 
2-5).  Consistent with our impression based on genotype calls and HET/HOM ratio, our methods 
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identified a cluster of contaminated samples among the 150 samples sequenced before August 
2010, with 45, 24, and 16 of these 150 samples estimated to have contamination levels of ?̂? ≥
1%, ≥ 2%, and ≥ 5%, respectively ( 
Table 2-2).    
 
Comparison of results (Figure 2-1, 
Table 2-2, Appendix Figure 2-S3) suggests that our contamination estimates were more 
sensitive than heterozygosity and HET/HOM ratio for detecting contaminated samples, 
particularly at lower levels of contamination.  For example, the average HET/HOM ratios among 
the ten samples with 2% ≤  ?̂? <  5% and the 254 samples with  ?̂? ≤ 1% were nearly 
Figure 2-5 Comparison of estimated contamination levels 
using sequence data with and without array genotype 
data for type 2 diabetes sequencing study. 
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identical:  1.92 and 1.91.  Investigation by the sequencing center suggested that contaminating 
samples were often in adjacent lanes to the targeted samples during library construction.  
Following modification of the library construction process in August 2010, none of the 149 
samples sequenced later that year had estimated contamination level ?̂? ≥ 0.5%,  (Figure 2-1C). 
 
 
Array 
Genotypes? 
Measure 
?̂? (sequence only) 
<1% 1-2% 2-5% ≥5% 
Yes Number of  samples 208 13 1 5 
(n=227)  − Before August 2010 81 13 1 5 
 − After August 2010 127 0 0 0 
RR discordance1 .0021 .0030 .0071 .0492 
RA discordance2 .0154 .0157 .0172 .0300 
AA discordance3 .0085 .0143 .0377 .176 
HET/HOM ratio4 1.92 1.84 2.16 2.66 
No Number of  samples 46 8 7 11 
(n=72)  − Before August 2010 24 8 7 11 
  − After August 2010 22 0 0 0 
 HET/HOM ratio4 1.87 1.88 1.88 2.64 
1. RR discordance:  Genotype discordance when array-based genotype is homozygous 
reference 
2. RA discordance:  Genotype discordance when array-based genotype is heterozygous 
3. AA discordance:  Genotype discordance when array-based genotype in homozygous non-
reference 
4. HET/HOM ratio:  Ratio of number of heterozygous genotypes to homozygous non-
reference genotypes 
 
Table 2-2 Summary of estimated contamination levels ?̂?, ratio of the numbers of heterozygous 
to non-reference allele homozygous  genotypes, and genotype discordance with array data for 
299 samples (227 with HumanOmni2.5 genotype array data) from type 2 diabetes study using 
sequence data only. 
To assess the impact of DNA sample contamination on genotyping accuracy, we 
compared genotypes called from the diabetes sequence data to the HumanOmni2.5 genotypes.  
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As expected, discordance between the sequence-based genotypes and the highly accurate 
array genotypes increased with increasing estimated contamination.  For homozygotes, average 
genotype discordance rates doubled in samples with 1% ≤  ?̂? ≤  5% compared to those with 
?̂? ≤ 1%, and increased by a factor of ~20 for ?̂? ≥ 5% ( 
Table 2-2, Figure 2-6).  The impact of contamination was less strong for heterozygous sites, but 
genotype discordance rates were still nearly doubled when ?̂? ≥ 5% compared to those in 
samples with ?̂? ≤ 1%.  The stronger effect of contamination on homozygous genotypes occurs 
because even modest numbers of contaminating sequence reads may result in calling a 
homozygote as a heterozygote.  
 
Discussion 
In this paper, we describe several methods to identify within-species DNA sample 
contamination based on the analysis of sequence read data and/or array-based genotype data.  
We first describe a mixture-model method that uses both sequence reads and array-based 
Figure 2-6 Genotype discordance between sequence-based and array-based genotypes as a 
function of estimated contamination level ?̂? in the type 2 diabetes sequencing study; 
contamination level estimates based on the combined sequence and genotype array data. 
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genotypes, and then show that this method can be extended naturally to identify contaminated 
samples when only sequence reads are available.  Both these sequence-based methods are 
highly sensitive, allowing detection of DNA sample contamination of 1% or less even with low-
coverage (4x) sequence data.  As expected, the combination of sequence reads and array-based 
genotypes results in greater sensitivity than sequence data alone, but the difference is modest 
(Figure 2-3).  Both our sequence-based mixture-model methods are more sensitive than 
traditional checks that test for an excess of heterozygous genotypes or an unusually high ratio 
of heterozygous to non-reference homozygous genotypes (HET/HOM ratio) – both of which can 
only detect contamination rates of >5-10% (Appendix Figure 2-S3).  A further advantage of our 
sequence-based methods is that they operate directly on the sequence reads (or BAM files), 
and so can be applied prior to variant calling.  In sequencing studies, the availability of array-
based genotypes for all samples allows identification of contaminating DNA samples and 
resolution of sample swaps.   
As with other analyses of short read sequence data, the sequence-based mixture-model 
methods are computationally intensive.  Given low-coverage (4x) whole-genome sequence data 
and focusing on sites with MAF > 5% from the Illumina 2.5M genotype array, our sequence-
based analyses required ~1.6 hours compute time per DNA sample on a single 2.8GHz 
processor.  Increasing sequence coverage results in an approximate linear increase in compute 
time.  To reduce computational burden, or if sequence read data come in large batches, we 
often do initial DNA contamination checking using a subset of the genome.  For example, 
analysis limited to chromosome 20 requires only ~2% the compute time, thus permitting rapid 
real-time early quality control and timely feedback to the sequence production group; for 
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contamination levels >1% and when the targeting and contaminating samples are unrelated, 
chromosome 20 analysis is also nearly as sensitive as analysis of the entire genome (Appendix 
Figure 2-S2). 
While our analysis of sequence-based methods focused on low-coverage whole-genome 
sequences, we have found that our sequence-based methods robustly identify contamination in 
other types of sequencing data.  For example, our methods have been successfully applied to 
targeted whole exome sequence data in the 1000 Genomes Project in addition to the low-
coverage sequence data.  We also found that our sequence-based methods robustly detect 
contamination in RNA-seq data with or without external genotypes.  In these data sets, focusing 
on exonic or on-target sites provided more accurate estimates of contamination levels than 
using all sites (data not shown).   
The models on which we base these methods (of course) do not capture all features of 
the sequencing experiment.  One such feature is reference bias, in which more reference-
sequence bases are observed than expected at a variant site, potentially resulting in an upward 
bias in estimated contamination levels.  Poorly aligned bases, inaccurate base quality scores, 
and asymmetric calling errors between bases may have the same effect.  Currently, both our 
sequence-based methods assume that the population from which the contaminating sample is 
drawn is known, and we observed reduced sensitivity with incorrect population allele 
frequencies.  When the population of the contaminating DNA sample is unknown, our method 
could be extended to iterate over alternative population allele frequencies to identify the most 
likely source population for a contaminant and to more precisely estimate the level of 
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contamination. Our implementation uses a simple error model. Preliminary evaluations of more 
sophisticated genotype error models made little difference to our results. 
In several sequencing studies, including the type 2 diabetes study described above, we 
have observed that our methods estimate a large fraction of samples to be contaminated at 
very low but non-zero levels, and likelihood ratio tests of 𝛼 = 0 against the alternative 𝛼 > 0 
result in apparent “contamination detection” for most samples.  In contrast, when we 
simulated uncontaminated DNA samples consistent with all our model assumptions, we found 
?̂? > 0 for only 33% of samples as opposed to 50% expected by a 1:1 mixture between χ02 and 
χ12  distributions8.  Furthermore, although both our likelihood-based methods naturally lead to 
confidence intervals for the level of estimated contamination, we generally find these intervals 
to be too narrow and do not recommend their use.  These contrasting findings likely reflect the 
impact of not modeling some of the sequencing experiment features described above. Careful 
examination of the impact of uncertainty in population allele frequency, of variation in read 
depth by genotype, of the fraction of duplicate reads, and of runs of homozygosity, could help 
to identify important features that are missing from the model.  We are working to include 
some of these features in our models, methods, and software. 
Identifying contaminated samples using array data alone provides the opportunity to 
avoid sequencing contaminated samples.  Both of our genotype-array-only methods – whether 
mixture model or regression based -- result in enhanced sensitivity compared to previous 
strategies that identify likely contaminated samples as those with low genotype call rates.  Low 
genotype call rates can identify heavily contaminated DNA samples as well as those that fail for 
other technical reasons.  However, in our experimentally contaminated samples genotyped 
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with the Metabochip, even at 5% contamination, all four samples had genotype call rates > 
99.5%, and even at 10% contamination, call rates were still between 96.8% and 97.9%.  Our 
mixture- and regression-based methods allowed accurate detection of contamination levels as 
low as 1%.   
In contrast to the sequence-based methods, our genotype-array-only methods have 
modest computational requirements.  For example, analysis of 36 samples genotyped at 
200,000 SNPs required <100 seconds on a single 2.8GHz processor for either the mixture-model 
or regression-based methods.  Further, these genotype-array-only methods were remarkably 
sensitive for contamination detection even with modest numbers of SNPs.  For example, using 
our experimentally contaminated samples and defining contamination detection as ?̂? ≥ 1%, 
power to detect contamination using the regression method based on 1000 random subsets of 
50, 100, 500, and 1000 homozygous SNPs was 37.3%, 59.6%, 99.0%, and 100%, respectively 
(Appendix Table 2-S1).  A confidence interval for the estimated contamination level can also be 
obtained from a simple linear regression model, ignoring uncertainty in key parameters such as 
the site-specific allele frequencies.  We found that, unlike the likelihood-based methods, the 
regression-based method provides reliable p-value and confidence interval with even a modest 
number of SNPs.  Of course, neither genotype-array-based method eliminates the possibility of 
introducing contamination during subsequent library preparation or sample sequencing. 
Our genotype-array-based mixture-model methods rely on good estimates of the means 
and variances of the genotype intensity clusters.  Estimation can be carried out across multiple 
samples (for each marker) or using a single sample (and pooling estimates across markers).  The 
single-sample method has the obvious advantage that it can be applied to one or a few 
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samples, permitting analysis to be carried out for small studies or on-the-fly as each sample is 
processed; a further advantage is that the method can analyze rare genotypes for which 
intensity distributions may be poorly estimated in methods that examine intensity distributions 
one site at a time, even across many individuals.  The single-sample method also has 
disadvantages.  The distribution of intensities across all SNPs for a given sample generally has 
larger variance than that for a given SNP across many samples9; for contamination detection, 
this larger variance leads to somewhat less sensitive contamination detection when small 
numbers of markers are available.  Regularizing parameters that share information across sites 
could increase the performance of the intensity-based mixture models for array data.  
Compared to the mixture-model method, the regression method has the advantage of 
providing a better calibrated hypothesis test for contamination.  In practice, running multiple 
methods on the array data will increase the confidence in analysis results. 
All our contamination detection methods assume the targeted DNA sample is 
contaminated by DNA from one other unrelated individual.  Given a fixed total contamination 
level 𝛼, contamination from two or more individuals increases the likelihood that multiple 
alleles will be observed at a marker and typically results in inflated estimates of 𝛼.  For 
example, when we simulated contaminating reads originating from two, three, and four 
contaminating samples, we observed 1-9%, 4-11%, 8-14% relative increases in the estimated 
contamination levels compared to actual contamination (Appendix Table 2-S2).  The joint 
sequence and array-based method, which relies mostly on genotype concordance rather than 
increased heterozygosity, showed only a small loss of precision with multiple contaminating 
samples.  In contrast, if a DNA sample is contaminated with DNA from a relative of the targeted 
32 
 
individual, the genetic similarity between the targeted and contaminating sample will result in 
an underestimate of 𝛼.  Simulation results suggest that given contamination at level 𝛼 from an 
individual sharing a fraction f of genes with the targeted sample results in an estimated 
contamination level of (1 − 𝑓)𝛼, for example, 𝛼/2 for sibling or parent-offspring pairs (data not 
shown).  
There are additional applications not yet covered by our method.  We have 
implemented and evaluated our genotype-array-only methods for Illumina genotyping platform 
only.  In principle, our methods can also support Affymetrix intensity data, as used in tools such 
as Birdseed10 or PennCNV11 which work with both Affymetrix and Illumina platforms.  For the 
sequence-based mixture models, an interesting application would be detection of 
heterogeneous cell populations within tumors.  Our experience suggests that even small 
contamination levels can be detected using only a small number of informative sites, so that 
this might well be practical.  
We have described an efficient set of methods to detect DNA sample contamination 
that should be useful for investigators planning or carrying out large-scale sequencing studies.  
For studies based on DNA samples with prior GWAS or other large-scale genotype data, we 
recommend using the genotype array-only methods to detect contaminated samples prior to 
sequencing.  These methods are useful even for small genotyping arrays with only 1000s of 
SNPs.  Based on results for the genotype-array analysis, an investigator may decide to obtain 
new DNA samples when there is evidence of contamination, or to eliminate those individuals 
from the study.  Whether or not the genotype-array-based contamination pre-screening is 
carried out, we recommend using the sequence-based methods to screen DNA samples for 
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contamination.  Based on the results of this sequence-based contamination analysis, the 
investigator might choose to eliminate from downstream analyses substantially contaminated 
samples, or to resample and resequence those individuals; for example, the 1000 Genomes 
Project chose to eliminate all DNA samples with estimated contamination ?̂? > 2%12. 
Application of these DNA contamination detection methods provides a sensitive method 
to identify contaminated samples and to maximize sequence data quality.  In addition, it may 
prove helpful to develop analysis methods that explicitly incorporate detection and estimation 
of DNA sample contamination into variant calling and/or downstream analysis.   
Acknowledgements 
This work was supported by NIH grants DK088398 and HG000376 (to M.B.), by NIH 
grants MH084698, HG006513 and HG005214 (to G.R.A.), and by NIH contract numbers 
HHSN268200782096C and HHSN268201100011I to support the Center for Inherited Disease 
Research. 
Web Resources 
The URLs for data presented herein are as follows: 
 Our initial description on sample identity verification (April 29, 2010) 
http://genome.sph.umich.edu/wiki/Verifying_Sample_Identities_-_Implementation 
 Contamination detection software package  
http://genome.sph.umich.edu/wiki/ContaminationDetection  
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Chapter 2 Appendix 
 
 
 
Figure 2-S1. Impact of Population Allele Frequency on Estimated Contamination Levels.  
Ratio between estimated contamination levels using different population allele frequencies 
with the sequence-only method.  
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Figure 2-S2. Estimated Contamination Levels Across Different Number of Markers.  
Comparison between each pair of intended contamination level, estimated contamination 
levels ?̂? using joint sequence and array-based method and ?̂? using sequence-only method 
across different number of markers. 
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Figure 2-S3. Comparison of Our Methods with ContEst Software 
Comparison of estimated contamination levels between joint sequence and array-based 
method and ContEst on the in-silico simulated data for chromosome 20. (A) intended 
contaminations versus ContEst estimates (B) Our joint sequence and array-based method 
versus ContEst estimates (C) ratio between the two estimates. 
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Figure 2-S4. Excess Heterozygosity in relation to Estimated Contamination 
Comparison of HET/HOM ratio to estimated contamination level ?̂? in the type 2 diabetes 
sequencing study based on analysis of (A) sequence and genotype array data (n=227) and (B) 
sequence data only (n=299).  
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Table 2-S1. Power and Type 1 Error of Genotype-Array Only Regression Method 
# Homozygous 
SNPs 
α=0 α=0.5% α=1% α=2% α=3% α=5% α=10% 
50 0.053 0.160 0.373 0.739 0.861 0.943 0.970 
100 0.060 0.228 0.596 0.946 0.994 1.000 1.000 
500 0.071 0.620 0.990 1.000 1.000 1.000 1.000 
1000 0.076 0.853 1.000 1.000 1.000 1.000 1.000 
For our experimentally contaminated sample, we selected different subset of homozygous SNPs 
and ran our regression method on those subsets. We then repeated this 1,000 times for each 
sample. The true level of contamination is shown at the top of the table. This values in the table 
show the proportion of tests which rejected the hypothesis of α=0 at the 0.05 level. 
 
 
Table 2-S2. Impact of multiple contaminating samples on estimated contamination 
 
Intended Contamination 
(Fixed Total) 
Sequence-only Sequence+Array 
?̂?𝟐/?̂?𝟏 ?̂?3/?̂?𝟏 ?̂?4/?̂?𝟏 ?̂?𝟐/?̂?𝟏 ?̂?3/?̂?𝟏 ?̂?4/?̂?𝟏 
α=1% 1.01 1.04 1.14 1.03 1.03 1.07 
α=2% 1.02 1.04 1.10 1.03 1.02 1.04 
α=5% 1.03 1.05 1.08 1.01 1.01 1.01 
α=10% 1.06 1.08 1.11 1.00 0.99 0.99 
α=20% 1.09 1.11 1.13 0.97 0.95 0.95 
The intended contamination was equally distributed across 2, 3, and 4 CEU samples. ?̂?𝑘 
represents estimated contamination obtained from k contaminating samples, and the fold-
enrichment of estimated contamination is average across 100 different runs. The results 
suggest that the sequence-only estimate of contamination tend to increase with multiple 
contaminating samples. In joint sequence and array-based method, multiple contaminating 
samples leads to slight overestimation of contamination when the contamination is small 
(α≤5%), and to underestimation when the contamination large (α≥10%). 
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Chapter 3  
Correcting for Sample Contamination in Genotype Calling of DNA 
Sequence Data 
 
AbstractB 
DNA sample contamination is a frequent problem in DNA sequencing studies, and may 
result in genotyping errors and reduced power for association testing. We recently described 
methods to identify within-species DNA sample contamination based on sequencing read data, 
showed that our methods can reliably detect and estimate contamination levels as low as 1%, 
and suggested strategies to identify and remove contaminated samples from sequencing 
studies. Here we propose methods to model contamination during genotype calling as an 
alternative to removal of contaminated samples from further analyses. We compare our 
contamination-adjusted calls to calls that ignore contamination and to calls based on 
uncontaminated data. We demonstrate that, for moderate contamination levels (5%-20%), 
contamination-adjusted calls eliminate 48-77% of the genotyping errors. For lower levels of 
contamination, our contamination correction methods produce genotypes nearly as accurate as 
those based on uncontaminated data. Our contamination correction methods are useful 
generally, but are particularly helpful for sample contamination levels from 2 to 20%. 
                                                     
B This work has been published: Flickinger, M., Jun, G., Abecasis, G. R., Boehnke, M., Kang, H. M. (2015). Correcting 
for sample contamination in genotype calling of DNA sequence data. Am J Hum Genet 97, 284-290. 
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Introduction 
 Advances in next-generation sequencing have resulted in higher sequencing throughput 
and lower sequencing costs, enabling a wide range of large-scale genomic studies. While the 
quality of sequence data is generally improving, methods and protocols are imperfect and 
errors inevitably occur. One such error is DNA sample contamination, in which DNA from two or 
more individuals is accidentally mixed. 
DNA sample contamination is a common occurrence in large-scale sequencing studies 
and can arise at many steps of the experiment: during sample collection; any time a sample is 
placed into or taken out of storage; during shipping, particularly if plates are not properly 
sealed or kept frozen; and during the many steps of preparing DNA sequencing libraries. For 
example, if barcoded samples are amplified in pools, template switching may occur if 
amplification conditions result in templates that are only partially extended at the end of each 
round, resulting in DNA from one sample paired with the barcode of another. Even if samples 
are sequenced without contamination on a particular run, a sample may be included in multiple 
runs and merged afterwards. If samples are improperly labeled or there are errors in the 
processing pipeline, reads from multiple samples may be combined in error.  
Screening for sample contamination is becoming a standard quality control step for DNA 
sequencing projects, and the patterns of contamination identified vary greatly. In the 1000 
Genomes Project, DNA samples were screened for contamination1 using our method2. Out of 
1166 sequenced samples, 39 had an estimated contamination level >3% and were dropped 
from analysis. In a psychiatric genetics study, we detected 64 DNA samples each with estimated 
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contamination >25%. These samples were traced back to two 96-well plates in which 
contamination likely occurred during shipping. In a type 2 diabetes exome sequencing study, 
~20% of a set of DNA samples had estimated contamination rates from 10-15%. Here, the 
apparent cause was a change in the library preparation protocol to allow processing of two 
samples at a time. Even in the most challenging contamination scenarios we have encountered, 
a subset of DNA samples show no evidence of contamination, so that most studies include a 
mixture of contaminated and uncontaminated DNA samples. 
If left uncorrected, contamination results in systematic genotype misclassification with a 
bias in favor of heterozygotes. This bias arises since when a mixture of two DNA samples is 
sequenced, the presence of the contaminating sample DNA makes it more likely that reads 
supporting different alleles at the same site will be present. The impact of contamination 
typically increases with the contamination level and decreases with sequencing depth. 
Here we propose likelihood-based methods that improve genotyping accuracy by 
explicitly modeling DNA sample contamination during genotype calling. We apply these 
methods to in-silico contaminated samples based on low-pass and high-depth sequence data 
from the 1000 Genomes Project and to actual contaminated samples from a type 2 diabetes 
exome sequencing project. We demonstrate that over a wide range of contamination levels and 
sequencing depths, modeling contamination can dramatically increase concordance between 
genotype calls and the true underlying genotypes, resulting in larger effective sample sizes for 
downstream genetic association studies than is possible by either ignoring contamination or 
dropping contaminated samples from the analysis. 
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Materials and Methods 
Outline 
First, we introduce notation and assumptions, and review our methods to detect DNA 
sample contamination2. Second, we describe our model for calling genotypes from sequence 
read data and propose a generalization of that model to account for DNA sample 
contamination. Third, we extend our model and method to provide even better results when 
the source of contamination is known and the corresponding sample is also sequenced. Finally, 
we describe a series of experiments and datasets used to evaluate the performance of our 
proposed methods. 
Detecting and estimating DNA sample contamination  
Consider the case where one DNA sample is contaminated by another2. Let 𝑔𝑖
(1)
 and 
𝑔𝑖
(2)
 be the genotypes for the intended and contaminating samples at variant site 𝑖 (1 ≤ 𝑖 ≤ 𝑀). 
Let 𝑏𝑖𝑗 be the observed base at position 𝑖 for read 𝑗 (1 ≤ 𝑗 ≤ 𝑅𝑖) and 𝑒𝑖𝑗 be a latent variable 
indicating whether a base calling error occurred (𝑒𝑖𝑗 = 1) or did not (𝑒𝑖𝑗 = 0). Finally, let 𝛼 be 
the proportion of reads from the contaminating sample and  be the proportion of samples 
that are contaminated. We assume that sites are independent, that reads at each site are 
independent, and that sequencing errors are equally likely to result in any of the three incorrect 
bases. 
To model the probability of observing a particular base, we employ the mixture model 
                        𝑃(𝑏𝑖𝑗|𝑔𝑖
(1)
,  𝑔𝑖
(2)
; 𝛼) = (1 − 𝛼)𝑃(𝑏𝑖𝑗|𝑔𝑖
(1)
) + 𝛼𝑃(𝑏𝑖𝑗|𝑔𝑖
(2))                       (1) 
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where 
𝑃(𝑏𝑖𝑗|𝑔𝑖) = 𝑃(𝑏𝑖𝑗|𝑔𝑖,  𝑒𝑖𝑗 = 1) 𝑃(𝑒𝑖𝑗 = 1) + 𝑃(𝑏𝑖𝑗|𝑔𝑖,  𝑒𝑖𝑗 = 0) 𝑃( 𝑒𝑖𝑗 = 0) 
We present the read probabilities allowing for error 𝑃(𝑏𝑖𝑗|𝑔𝑖,  𝑒𝑖𝑗) in Table 3-1. We estimate 
the probability of a read error as 𝑃(𝑒𝑖𝑗 = 1) = 10
−𝑄𝑖𝑗/10  and 𝑃(𝑒𝑖𝑗 = 0) = 1 − 𝑃(𝑒𝑖𝑗 = 1), 
where  𝑄𝑖𝑗  is the phred-scaled base quality score for the sequence data
3. To estimate the 
genotype probability (𝑔𝑖), we use allele frequencies from the population from which the 
sample was drawn and assume Hardy-Weinberg equilibrium. Allele frequencies can be 
estimated from a closely related reference population (for example, HapMap or 1000 
Genomes), from array-based genotypes from the same population, or even from the proportion 
of reads that carry each allele across all sequenced samples. 
 
Taking expectations over the unknown genotypes and assuming all reads and loci are 
independent, we write the likelihood for contamination level 𝛼 in a sample as  
𝐿(𝛼) = 𝑃(𝐵|𝛼) = ∏ ∑ ∑ {𝑃(𝑔𝑖
(1)
)𝑃(𝑔𝑖
(2)
) ∏ [(1 − 𝛼)𝑃(𝑏𝑖𝑗|𝑔𝑖
(1)
) + 𝛼𝑃(𝑏𝑖𝑗|𝑔𝑖
(2)
)]
𝑅𝑖
𝑗=1
}
𝑔
𝑖
(2)
𝑔
𝑖
(1)
𝑀
𝑖=1
 
For each sample, we first maximize 𝐿(𝛼) using a grid search in the interval 0.0 ≤  ≤ 0.5 and 
then apply Brent’s4 algorithm to obtain the maximum likelihood estimate of α. By using 
information across a large number of variants 𝑀, we determine if the observed reads are better 
explained by a single sample or a combination of two samples with mixing proportion 𝛼. Even if 
not all markers are independent, there is little impact on the estimation of 𝛼. 
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True 
genotype 
Base Read 
Error 
Indicator 𝑷(𝒃𝒊𝒋 = A) 𝑷(𝒃𝒊𝒋 = B) 𝑷(𝒃𝒊𝒋 = E) 
g=AA e=0 1 0 0 
 e=1 0 1/3 2/3 
g=AB e=0 1/2 1/2 0 
 e=1 1/6 1/6 2/3 
g=BB e=0 0 1 0 
 e=1 1/3 0 2/3 
Table 3-1 Conditional probability 𝑷(𝒃𝒊𝒋 | 𝒆𝒊𝒋, 𝒈𝒊) of read 𝒃𝒊𝒋 given true genotype 𝒈𝒊 and read 
error 𝒆𝒊𝒋 Assumes a biallellic site with alleles A and B; E represents any base other than A or B. 
𝑒𝑖𝑗 = 0 corresponds to a sequencing error; or 1 corresponds to a correct base call. 
Genotype likelihoods for contaminated sequence data: source unknown  
Having estimated the contamination level 𝛼 for sample k, we explicitly model 
contamination during genotype calling using the estimated sample-specific contamination rate 
?̂?𝑘. Treating the genotypes of the intended and contaminating genotypes as the unknowns, we 
calculate the likelihood for the combination of genotypes using the probability (1) as  
𝐿(𝑔𝑖
(1), 𝑔𝑖
(2)|𝐵𝑖; ?̂?𝑘) = 𝑃(𝐵𝑖|𝑔𝑖
(1), 𝑔𝑖
(2); ?̂?𝑘) = ∏ [(1 − ?̂?𝑘)𝑃(𝑏𝑖𝑗|𝑔𝑖
(1)
) +  ?̂?𝑘𝑃(𝑏𝑖𝑗|𝑔𝑖
(2)
)]
𝑅𝑖
𝑗=1
 
where 𝐵𝑖 = {𝑏𝑖𝑗| 𝑗 = 1 … 𝑅𝑖} is the set of bases overlapping position 𝑖 in the sequence reads 
that cover the variant site. Usually, we do not know the genotype of the contaminating sample, 
and so we sum over this unknown variable to obtain the genotype likelihood  
𝐿(𝑔𝑖
(1)|𝐵𝑖; ?̂?𝑘) = 𝑃(𝐵𝑖|𝑔𝑖
(1); ?̂?𝑘) = ∑ [𝑃(𝑔𝑖
(2)
)𝑃(𝐵𝑖|𝑔𝑖
(1), 𝑔𝑖
(2); ?̂?𝑘)]𝑔
𝑖
(2) . 
In contrast to the analysis in which we identified contaminated samples and estimated 
contamination level 𝛼 for each sample 𝑘 using a list of known variant sites and allele 
frequencies, during genotype calling we examine every site. This step requires allele 
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frequencies at each site, which we estimate using the EM algorithm5 to maximize the above 
likelihood. Thus, we estimate the allele frequency as: 
𝑓?̂? = arg max𝑓𝑖 ∏ [∑ 𝑃(𝑔𝑖𝑘|𝑓𝑖)𝑃(𝐵𝑖𝑘|𝑔𝑖𝑘;  ?̂?𝑘)
𝑔𝑖𝑘
]
𝑛
𝑘=1
 
where 𝑔𝑖𝑘 is the true genotype for individual 𝑘 (1 ≤ 𝑘 ≤ 𝑛) at site 𝑖. Given the allele frequency 
estimate 𝑓𝑖, we estimate the genotype probabilities assuming Hardy-Weinberg equilibrium.  
Finally, to call a genotype for an individual at locus 𝑖, we select the value of 𝑔𝑖
(1)
 with the 
highest likelihood. We calculate the corresponding genotype dosage (𝐷𝑖  ranging from 0 to 2) for 
bi-allelic sites by taking a weighted average of the number of alternative alleles for each of the 
possible genotypes 𝑔𝑖
(1)
  
𝐷𝑖 =
𝑃(𝑔𝑖
(1)
= AR | 𝐵𝑖; ?̂?, 𝑓?̂?) + 2 ∙ 𝑃(𝑔𝑖
(1)
= AA | 𝐵𝑖; ?̂?, 𝑓?̂?)
𝑃(𝑔𝑖
(1)
= RR | 𝐵𝑖; ?̂?, 𝑓?̂?) + 𝑃(𝑔𝑖
(1)
= AR | 𝐵𝑖; ?̂?, 𝑓?̂?) + 𝑃(𝑔𝑖
(1)
= AA | 𝐵𝑖; ?̂?, 𝑓?̂?)
                    (2) 
where 𝑅 and 𝐴 are the reference and alternate alleles and 
𝑃(𝑔𝑖
(1)
| 𝐵𝑖; ?̂?, 𝑓?̂?) ∝ 𝑃(𝐵𝑖|𝑔𝑖
(1); ?̂?) 𝑃(𝑔𝑖
(1); 𝑓?̂?).  
Genotype likelihoods for contaminated sequence data: source known 
If the identity of the contaminating sample is known, as in the type 2 diabetes example 
described in the Introduction, we can use that information to improve genotype calls. In that 
case, we examine all available data from the paired DNA samples and call their genotypes 
simultaneously by considering all potential 3 x 3 = 9 genotype pairs (𝑔𝑖
(1)
, 𝑔𝑖
(2)
). Let 𝐵𝑖
(1)
=
{𝑏𝑖𝑗
(1)
| 𝑗 = 1 … 𝑅𝑖
(1)
}  and 𝐵𝑖
(2)
= {𝑏𝑖𝑗
(2)
| 𝑗 = 1 … 𝑅𝑖
(2)
} be the observed bases for reads labeled 
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as originating from samples 1 and 2, respectively, and let ?̂?(1) and ?̂?(2) be the estimated 
contamination levels for those two samples. We then write the joint likelihood for the paired 
samples as  
𝐿(𝑔𝑖
(1), 𝑔𝑖
(2)|𝐵𝑖
(1)
𝐵𝑖
(2)
; ?̂?(1), ?̂?(2))
= ∏ [(1 − ?̂?(1))𝑃(𝑏𝑖𝑗
(1)
|𝑔𝑖
(1)
) +  ?̂?(1)𝑃(𝑏𝑖𝑗
(1)
|𝑔𝑖
(2)
)]
𝑅𝑖
(1)
𝑗=1
× ∏ [?̂?(2)𝑃(𝑏𝑖𝑗
(2)
|𝑔𝑖
(1)
) + (1 − ?̂?(2))𝑃(𝑏𝑖𝑗
(2)
|𝑔𝑖
(2)
)]
𝑅𝑖
(2)
𝑗=1
 
This likelihood can also be calculated for different possible contaminating samples and 
compared to find the most likely source contamination (assuming both samples were 
sequenced).  
When inconvenient to work with the joint likelihood (such as when calculating per-
individual dosages), we calculate per-sample genotype likelihoods by marginalizing over the 
partner genotype.  
𝐿(𝑔𝑖
(1)|𝐵𝑖
(1)
𝐵𝑖
(2)
; ?̂?(1), ?̂?(2)) = ∑ [𝑃(𝑔𝑖
(2)
)𝑃(𝐵𝑖
(1)
𝐵𝑖
(2)
|𝑔𝑖
(1), 𝑔𝑖
(2); ?̂?(1), ?̂?(2))]
𝑔
𝑖
(2)
 
We also calculate these individual likelihoods prior to genotype refinement for low-pass 
sequence data (see below). 
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LD refinement for low-pass sequence data  
Genotype refinement using linkage disequilibrium (LD) on low-pass sequence data 
leverages information about surrounding markers to help infer haplotypes and improve 
genotype accuracy6,7. After adjustment for contamination, we use Beagle6 on our genotype 
likelihoods for low-pass (4-6x) whole genome data to refine and improve genotype calls. Such 
an adjustment is less important for exome sequence data because of insufficient flanking 
markers to infer haplotypes accurately. 
Experimental data  
To construct in-silico contaminated samples to test our methods, we chose 198 
European 1000 Genomes Phase 1 samples1 with (a) low-pass (4-6x) genome sequence data, (b) 
high-depth (50-150x) whole exome sequence data, (c) Illumina HumanOmni2.5 and 
HumanExome chip data, and (d) estimated contamination levels  ?̂? < 0.5% for chip and 
sequence data. We chose two samples at a time (without replacement) and combined 
sequence reads to achieve synthetic contamination levels 𝛼 from 2% to 30%. We paired 
samples with similar depths so as to approximately preserve total read counts and varied the 
proportion of contaminated samples  in each simulation from 0 to 100%.  
We also analyzed 1,503 samples from a type 2 diabetes exome sequencing project 
(average sequencing depth ~100x), 1,009 of which (67%) were estimated to have 
contamination level ?̂? > 5%. In this study, we learned after sequencing was completed that 
changes to sequencing library preparation protocols that were designed to improve efficiency 
and reduce cost resulted in contamination due to template switching during PCR amplification 
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of pairs of barcoded samples. In this case, we could reconstruct the identity of the 
contaminating sample by checking experimental records to identify samples that were 
amplified together.  
Evaluation  
For both examples, we compared sequence-based best-guess genotypes and genotype 
dosages to available array-based genotypes to estimate genotype concordance and squared 
Pearson’s correlation 𝑟2 between true genotypes and estimated genotype dosages. The 
genotypes for the in-silico contaminated low-pass samples were LD-refined, and then compared 
to all 41,847 Illumina HumanOmni2.5 genotype array chromosome 20 SNPs. Genotypes for in-
silico contaminated high-depth samples were compared to all 33,884 SNPs from the Illumina 
HumanExome array that were polymorphic within the 198 1000 Genomes Project samples. 
Genotypes for the type 2 diabetes example were compared to all 3,881 SNPs from the 
Affymetrix 6.0 array that overlapped the targeted sequence regions and were variable within 
the sequenced samples. 
Results 
In-silico contaminated data: contaminating sample unknown  
When we did not model contamination, increasing DNA contamination levels (α) 
resulted in decreasing concordance between sequence and array genotypes. For low-pass 
whole genome sequence data, as α increased from 2% to 30%, total genotype concordance 
decreased from 98.1% to 83.8%, compared to an average concordance of 98.9% for 
uncontaminated samples (Figure 3-1A; Appendix Table 3-S1). For high-depth exome sequence 
50 
 
data, total concordance decreased from 99.6% to 92.9% over the same contamination range 
compared to 99.8% for uncontaminated samples (Figure 3-1B; Appendix Table 3-S1). Similarly, 
𝑟2 values for genotype dosages decreased from >0.96 to <0.75 as α increased from 2% to 30% 
(Figure 3-1CD). Genotyping errors resulted in an increase in heterozygous calls roughly equal to 
α for the high-depth data and α/2 for the low-pass data (Appendix Figure 3-S1). The impact of 
contamination was greater for common variants than for rare ones (Appendix Table 3-S1), 
corresponding to the greater probability of a contamination resulting in a false heterozygote. 
 
Figure 3-1 Effects of contamination adjustment on constructed 
contaminated DNA samples: genotype concordance and 𝒓𝟐. Each 
point represents overall genotype concordance or dosage  𝑟2 for 
contaminated samples when the proportion of contaminated samples 
π=50% 
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Applying our method to these contaminated samples markedly increased genotype 
concordance and genotype dosage 𝑟2. Estimated sample contamination levels ?̂?𝑘 closely 
matched intended 𝛼 values (Appendix Table 3-S2). By accurately modeling contamination, we 
reduced the difference in genotype concordance rates between the contaminated and 
uncontaminated samples by up to 60-80% for the high-depth exomes and up to 50-80% for the 
LD-refined low-pass genomes (Figure 3-1AB) for contamination levels 5%-20%. We observed a 
similar pattern for 𝑟2 (Figure 3-1CD). For the low-pass data, these improvements were seen 
only after LD-refinement (Appendix Figure 3-S2).   
Joint calling uncontaminated samples with contaminated samples had little effect on 
the genontypes for the uncontaminated samples. For low-pass data, when the proportion of 
contaminated samples 𝜋=50% and contamination levels 𝛼 ≤ 30%, the largest observed 
reduction in genotype concordance for uncontaminated samples was 0.4%; average reductions 
were ~0.2%. Results changed only slightly as we varied the proportion of contaminated samples 
from 𝜋=5% to 90% (Figure 3-2). For high-depth data, the effect using our contamination-aware 
likelihoods when calling genotypes for uncontaminated samples was negligible for all 𝜋 and 𝛼 
(Appendix Table 3-S3). 
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In-silico contaminated data: contaminating sample known 
When the source of the contaminating DNA sample was known and sequence data for 
both samples was available, modeling this information explicitly further improved concordance 
with array genotypes. For low-pass data, adding the pair information reduced the difference in 
concordance by an additional ~25% as 𝛼 increased from 2% to 20% (Figure 3-1A). However, at 
α=30%, concordance was actually slightly lower. This reduction in concordance appears only 
after LD-adjustment on the data; it may be the result of a loss of information from marginalizing 
our pairwise genotype likelihoods as required for analysis with Beagle. Improvements to 𝑟2 
Figure 3-2 Effects of increasing proportion of contaminated 
samples 𝜋 on genotype concordance for various levels of 
contamination 𝛼 
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ranged from 0.1% to 1.3% for α=2% to 20%. For high-depth data, we did not see a meaningful 
difference in concordance or 𝑟2 when using the known pair information (Figure 3-1B). 
In-silico contaminated data: association information  
Ultimately we wish to use the sequence-based genotypes to test for disease or trait 
association. In association analysis, we can choose one of three strategies: (1) ignore 
contamination, (2) exclude highly contaminated samples from analysis, or (3) adjust for 
contamination. To estimate the relative efficiencies of these three strategies, we note that 
effective sample size scales linearly with n𝑟2, the product of sample size and the squared 
correlation between the true genotype and the sequence-based genotype dosages8. Since even 
contaminated samples provide information about the true underlying genotype (𝑟2>0), 
including contaminated samples could provide association information even when 
contamination is ignored. The reduction in sample size due to contamination is at least 80% 
smaller when applying our correction compared to dropping contaminated samples (Table 3-2). 
In our evaluations, we maximized effective sample size when adjusting for contamination and 
using all samples, whether contaminated or not. For example, when all samples are 
contaminated at 𝛼 = 10%, association information for the low-pass data is reduced by 10.6% if 
we ignore contamination and 4.0% if we correct for contamination (compared to 8.0% and 2.5% 
respectively for high-depth data). In this example, where all samples are contaminated, it would 
have been impractical to exclude contaminated samples from association analyses.  
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 Low-Pass 
 % of Samples Contaminated 
Method 5% 10% 25% 50% 75% 90% 100% 
    Adjusted 194 194 193 192 191 190 190 
    Ignored 193 193 190 186 182 179 177 
    Dropped 184 174 144 96 47 18 0 
 High-Depth 
 % of Samples Contaminated 
Method 5% 10% 25% 50% 75% 90% 100% 
    Adjusted 195 195 195 194 194 193 193 
    Ignored 195 194 192 189 186 184 182 
    Dropped 186 176 146 98 48 18 0 
Table 3-2 Effective sample size for association test Shown here are the effective sample size 
estimates when α=10% and total sample size is 198 under three scenarios: all samples included 
and adjusted with our method (“adjusted”), all samples included but contamination ignored 
(“ignored”), and contaminated samples (α ̂>0.01) removed from analysis (“dropped”) 
In-silico contaminated data: impact of over- or underestimating contamination  
To evaluate whether misspecified values of α could result in decreased genotype 
quality, we ran simulations in which we scaled the contamination estimate ?̂? by 0.5, 0.75, 1.5, 
and 2 for samples in which the true 𝛼=5%, 10%, or 15%. Overestimating ?̂? had little impact on 
total concordance and 𝑟2 while underestimating contamination more negatively affected both 
statistics (Figure S3). For the low-depth data, overestimating ?̂? by 1.5x actually resulted in 
better concordance then using the “true” ?̂?; this effect was only observed after LD-refinement 
The difference in concordance when reducing α by half was at least 40% greater than difference 
from of doubling α for the low-pass samples; there was very little difference for the high-depth 
samples. The negative impact of inflated ?̂? estimates for samples that were not contaminated 
was very modest compared to the benefits of modeling contamination for the remaining 
samples.  
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Type 2 diabetes data  
Convinced of the value of adjusting for contamination, we next applied our method to 
data from the type 2 diabetes exome sequencing project. In these data, ?̂?=67% of samples were 
contaminated and we knew the likely contaminating sample. When we applied our correction 
methods, concordance with array genotypes dramatically improved: the average per-sample 
concordance increased from 94.5% to 99.4% (a 9-fold reduction in discordance), further 
increasing to 99.6% (a 14-fold reduction in discordance) when we both modeled contamination 
and used knowledge of its source. Similar patterns were observed for non-reference 
concordance and  𝑟2 (Table 3-3). 
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 ?̂? 
# 
Samples Ignored Adjusted Paired 
Total Concordance 0-1% 202 0.998 0.998 0.998 
 1-5% 293 0.996 0.998 0.998 
 5-10% 218 0.958 0.997 0.998 
 10-15% 591 0.920 0.993 0.996 
 15-20% 169 0.878 0.984 0.992 
 >20% 30 0.841 0.950 0.971 
 ALL 1503 0.945 0.993 0.996 
Non-Ref 
Concordance 0-1% 
202 
0.996 0.997 0.997 
 1-5% 293 0.992 0.995 0.995 
 5-10% 218 0.908 0.993 0.994 
 10-15% 591 0.833 0.985 0.991 
 15-20% 169 0.760 0.964 0.983 
 >20% 30 0.702 0.890 0.936 
 ALL 1503 0.882 0.985 0.991 
r2 0-1% 202 0.997 0.998 0.998 
 1-5% 293 0.994 0.996 0.996 
 5-10% 218 0.929 0.995 0.996 
 10-15% 591 0.863 0.990 0.994 
 15-20% 169 0.791 0.977 0.989 
 >20% 30 0.725 0.930 0.946 
 ALL 1503 0.905 0.990 0.994 
Table 3-3 GWAS concordance for type 2 diabetes exome sequencing data (Mean per-sample 
genotype accuracy with the GWAS data when we ignore contamination, adjust without regard 
for the source of contamination, and adjust using known contamination source) 
Discussion 
We have shown that genotyping accuracy for contaminated samples can be dramatically 
improved by modeling contamination using a mixture model. For example, in the type 2 
diabetes exome sequencing example, our method reduced genotype discordance by 14-fold 
(4.2% to 0.3%) for 𝛼=5-10% contaminated samples. Consistent with our previous study, we 
observed that even low levels of contamination (e.g., 𝛼=2-5%) can result in increases in 
genotype discordance of >2-fold. Our correction method nearly eliminates the impact of low 
levels of DNA contamination (𝛼=2-5%) and reduces by >80% genotype discordance incurred by 
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moderate level of DNA contamination (𝛼=5-15%) in the type 2 diabetes exome sequencing 
examples. We expect our method to be particularly useful when a large fraction of sequenced 
samples are contaminated at small to moderate levels (𝛼=2-15%). Below we discuss the 
robustness of our approach when model assumptions are not met, and explore other scenarios 
where these or similar modeling approaches might be useful. 
We demonstrated (Appendix Figure 3-S3) that genotype calling methods that model 
contamination perform best when the contamination level 𝛼 is well estimated and that 
underestimating 𝛼 is more detrimental than overestimating it. Situations that may lead to 
deflated contamination estimates are (1) the use of misspecified allele frequency estimates 
(incorrect population as well as systematic overestimates or underestimates; data not shown), 
(2) contamination from related individuals2, or (3) limited sequencing library complexity which 
results in decreased heterozygosity. If one or more of these situations is suspected, modestly 
inflating (2-5%) the estimated contamination level ?̂? when correcting for contamination may 
improve overall genotype accuracy. 
As long as contamination affects case and control samples similarly, we do not expect 
contamination adjustments to increase the rate of false positive findings in downstream 
association studies. For single-variant associations, results depend on accurate estimations of 
allele frequency differences in cases and controls. As long as contamination patterns do not 
differ drastically in the cases and controls and there are no issues of population stratification, 
we can accurately estimate allele frequencies after correction (Appendix Figure 3-S4). For rare-
variant association, contaminated samples may appear to carry high numbers of rare 
heterozygous variants when analyzed with standard protocols. Our proposed correction will 
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decrease the number of false positive heterozygotes (Appendix Figure 3-S5), so false positive 
associations will be less likely. 
While we have focused on sequencing genomic DNA, in principle our methods can be 
used for other sequencing studies as well. For example, we have used our methods to identify 
contamination in RNA-seq experiments. Using our existing method and restricting analyses to 
expressed exons in protein-coding genes, we detected that 11 of 249 RNA-seq samples were 
contaminated by >2%. Detection and estimation of contamination in these experiments may be 
made more robust by accounting for allele-specific expression (ASE), where gene transcription 
varies based on allele; we are exploring this possibility.  
We described the methods in this paper specifically in the context of biallelic SNPs. 
Extension to multiallelic SNPs is straightforward, requiring only that we sum over a larger 
number of possible genotypes. Genotyping of other variant types, such as indels and structural 
variants, is also affected by contamination. We expect that the same principles, focused on 
modeling the observed data as a mixture of two samples, can be usefully applied to these more 
complex situations. 
We observed that the LD-aware genotype refinement algorithm improves genotype 
accuracy for low-pass sequence data. However, accuracy was still substantially lower than for 
uncontaminated data when the contamination level 𝛼 was high. This may be due in part to the 
fact that our LD-aware genotype refinement algorithm is not aware of the possibility of 
contamination. With increasing interest in whole genome sequencing studies, accounting for 
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the contamination in the genotype refinement step has the potential to further improve 
genotyping and phasing accuracy. 
Our contamination modeling methods are implemented in the program cleanCall. 
Source code for this program is available online. cleanCall requires sequencing data in samtools 
[Li et al. 2009] pileup format. Extracting pileups only for variant sites allows cleanCall to read 
data quickly compared to scanning large BAM files. The total runtime for cleanCall is 
comparable to other simple likelihood-based genotype callers; modest additional time is spent 
estimating allele frequencies via the EM algorithm, but the average number of iterations at a 
given site is minimal (2-5) and does not significantly affect overall performance. 
We developed methods to correct for DNA contamination in variant calling by extending 
our likelihood-based framework to detect and estimate contamination. Our correction methods 
improve genotype calling accuracy and association power compared to ignoring contamination 
or discarding contaminated samples. Even if the contamination level is small (?̂?<5%), we 
observe considerable improvement in genotype accuracy using our correction methods. Our 
methods are effective both for high-depth and low-pass data, and given the ubiquity of DNA 
sample contamination, we expect that our methods to be of real benefit to a large number of 
DNA sequencing studies.  
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Chapter 3 Appendix 
 
Figure 3-S1 – Overcalling heterozygous genotypes in contaminated data 
These boxplots  show the relative excess heterozygote genotypes: the average number of 
heterozygous genotypes from sequence-based analyses of sites genotyped using arrays, divided 
by the number of heterozygous genotypes in the array data (per sample) 
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Figure 3-S2 – Effects of LD-refinement on adjusted calls for low-pass data 
We saw a modest improvement in genotype calls in the low-pass data prior to LD-refinement; 
after refinement, the effects were substantial. Each color represents the value for 𝛼 used to 
simulate in-silico contamination 
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Figure 3-S3 – Effects of incorrect estimation of the contamination level  
Effects of incorrect estimation of  on total genotype concordance and dosage 𝑟2 for 
contaminated and uncontaminated samples when 𝜋 = 0.50. The scaling factor applied to ?̂? is 
listed along the x-axis. The values for “UN” are the measures where all samples are 
uncontaminated and “IG” are the values where contamination is ignored.  
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Figure 3-S4 – Allele frequency estimation with contaminated data 
This is a qq-plot comparing the distribution of allele frequency estimates (𝑓) from the array-
based genotypes against the distribution of allele frequencies calculated from the sequencing-
based genotypes for both the uncontaminated samples and contaminated samples after 
adjustment (𝛼 = 0.15). We have scaled the frequencies using a –log10 transformation to focus 
on the rarer variants. 
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Figure 3-S5 – False positive heterozygote SNPs 
Here we have plotted the distribution of the ratios of heterozygous SNPs to non-reference 
homozygous SNPs for samples with 𝛼 = 15%. We expect ratios close to 2 based on 
observations from genotype data in other studies. The high ratio for samples where 
contamination was ignored likely indicates many false positive heterozygote genotypes. 
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Table 3-S1 – Genotype accuracy for contaminated samples 
Total genotype concordance and dosage r2 for contaminated samples when 𝜋=50% of the 
samples in the call set were contaminated. 
  Low-Pass    High-Depth 
 𝛼 Ignored Adjusted Paired   𝛼 Ignored Adjusted Paired 
Total 0% 0.989  Total 0% 0.997 
Concordance 2% 0.981 0.985 0.985  Concordance 2% 0.996 0.996 0.996 
 5% 0.967 0.982 0.983   5% 0.992 0.996 0.996 
 10% 0.941 0.979 0.981   10% 0.979 0.994 0.994 
 15% 0.913 0.970 0.976   15% 0.965 0.992 0.991 
 20% 0.886 0.957 0.966   20% 0.950 0.987 0.987 
 30% 0.838 0.910 0.908   30% 0.929 0.971 0.971 
Non-Ref 0% 0.973  Non-Ref 0% 0.981 
Concordance 2% 0.955 0.963 0.965  Concordance 2% 0.971 0.975 0.975 
 5% 0.925 0.957 0.960   5% 0.945 0.971 0.971 
 10% 0.869 0.949 0.955   10% 0.868 0.959 0.959 
 15% 0.806 0.930 0.942   15% 0.791 0.944 0.944 
 20% 0.755 0.900 0.920   20% 0.719 0.913 0.913 
 30% 0.669 0.798 0.794   30% 0.638 0.817 0.817 
r2 0% 0.982  r2 0% 0.990 
 2% 0.970 0.976 0.977   2% 0.984 0.986 0.986 
 5% 0.949 0.972 0.974   5% 0.970 0.984 0.984 
 10% 0.907 0.967 0.971   10% 0.923 0.978 0.978 
 15% 0.858 0.955 0.963   15% 0.871 0.971 0.971 
 20% 0.813 0.936 0.949   20% 0.815 0.955 0.955 
 30% 0.729 0.863 0.859   30% 0.740 0.907 0.907 
Allele Freq <1% 0% 0.997  Allele Freq <1% 0% 1.000 
Concordance 2% 0.996 0.996 0.997  Concordance 2% 1.000 1.000 1.000 
 5% 0.994 0.996 0.996   5% 0.999 1.000 1.000 
 10% 0.994 0.995 0.996   10% 0.999 0.999 0.999 
 15% 0.992 0.993 0.994   15% 0.997 0.999 0.999 
 20% 0.990 0.991 0.991   20% 0.995 0.999 0.999 
 30% 0.985 0.987 0.985   30% 0.991 0.998 0.998 
Allele Freq 1-5% 0% 0.993  Allele Freq 1-5% 0% 0.998 
Concordance 2% 0.990 0.991 0.992  Concordance 2% 0.997 0.997 0.997 
 5% 0.986 0.989 0.990   5% 0.996 0.997 0.997 
 10% 0.978 0.988 0.990   10% 0.990 0.996 0.996 
 15% 0.966 0.983 0.986   15% 0.983 0.995 0.995 
 20% 0.955 0.976 0.979   20% 0.971 0.992 0.992 
 30% 0.933 0.952 0.942   30% 0.953 0.983 0.983 
Allele Freq >5% 0% 0.986  Allele Freq >5% 0% 0.992 
Concordance 2% 0.976 0.981 0.981  Concordance 2% 0.987 0.989 0.989 
 5% 0.957 0.977 0.979   5% 0.974 0.987 0.987 
 10% 0.922 0.973 0.976   10% 0.934 0.981 0.981 
 15% 0.881 0.962 0.969   15% 0.891 0.974 0.974 
 20% 0.845 0.946 0.958   20% 0.849 0.960 0.960 
 30% 0.781 0.884 0.884   30% 0.793 0.912 0.912 
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Table 3-S2 – Estimated contamination (mean and SD) for constructed contaminated samples 
 Low-Pass High-Depth 
Intended 𝜶 (%) Mean ?̂? SD ?̂? Mean ?̂? SD ?̂? 
2 1.8 0.5 2.2 0.2 
5 4.6 0.7 5.6 0.5 
10 9.4 1.0 10.7 0.7 
15 14.1 1.4 15.4 1.0 
20 18.7 1.7 19.8 1.2 
30 27.6 2.4 27.3 2.2 
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 Table 3-S3 – Genotype accuracy for uncontaminated samples  
Total genotype concordance and r2 for the uncontaminated samples when 𝜋=50% of the 
samples in the call set were contaminated. 
  Low-Pass    High-Depth 
 𝛼 Ignored Adjusted Paired   𝛼 Ignored Adjusted Paired 
Total 0% 0.989  Total 0% 0.997 
Concordance 2% 0.988 0.988 0.988  Concordance 2% 0.997 0.997 0.997 
 5% 0.987 0.988 0.988   5% 0.997 0.997 0.997 
 10% 0.986 0.987 0.988   10% 0.997 0.997 0.997 
 15% 0.986 0.987 0.987   15% 0.997 0.997 0.997 
 20% 0.985 0.986 0.987   20% 0.997 0.997 0.997 
 30% 0.985 0.986 0.986   30% 0.997 0.997 0.997 
Non-Ref 0% 0.973  Non-Ref 0% 0.981 
Concordance 2% 0.971 0.971 0.971  Concordance 2% 0.981 0.981 0.981 
 5% 0.970 0.971 0.972   5% 0.980 0.980 0.980 
 10% 0.967 0.969 0.970   10% 0.981 0.980 0.980 
 15% 0.966 0.969 0.970   15% 0.980 0.979 0.979 
 20% 0.965 0.967 0.968   20% 0.981 0.980 0.980 
 30% 0.964 0.966 0.966   30% 0.980 0.979 0.979 
r2 0% 0.982  r2 0% 0.990 
 2% 0.980 0.981 0.981   2% 0.990 0.990 0.990 
 5% 0.979 0.981 0.981   5% 0.989 0.989 0.989 
 10% 0.978 0.980 0.980   10% 0.989 0.989 0.989 
 15% 0.977 0.980 0.980   15% 0.989 0.989 0.989 
 20% 0.977 0.979 0.979   20% 0.990 0.989 0.989 
 30% 0.976 0.978 0.978   30% 0.989 0.989 0.989 
Allele Freq <1% 0% 0.997  Allele Freq <1% 0% 1.000 
Concordance 2% 0.997 0.997 0.997  Concordance 2% 1.000 1.000 1.000 
 5% 0.997 0.997 0.997   5% 1.000 1.000 1.000 
 10% 0.996 0.997 0.997   10% 1.000 1.000 1.000 
 15% 0.997 0.997 0.997   15% 1.000 1.000 1.000 
 20% 0.997 0.997 0.997   20% 1.000 1.000 1.000 
 30% 0.997 0.997 0.997   30% 1.000 1.000 1.000 
Allele Freq 1-5% 0% 0.993  Allele Freq 1-5% 0% 0.998 
Concordance 2% 0.993 0.993 0.993  Concordance 2% 0.998 0.998 0.998 
 5% 0.993 0.993 0.993   5% 0.998 0.998 0.998 
 10% 0.992 0.993 0.993   10% 0.998 0.998 0.998 
 15% 0.992 0.993 0.993   15% 0.998 0.998 0.998 
 20% 0.992 0.992 0.992   20% 0.998 0.998 0.998 
 30% 0.991 0.992 0.992   30% 0.998 0.998 0.998 
Allele Freq >5% 0% 0.986  Allele Freq >5% 0% 0.992 
Concordance 2% 0.985 0.985 0.985  Concordance 2% 0.992 0.991 0.991 
 5% 0.984 0.985 0.985   5% 0.991 0.991 0.991 
 10% 0.982 0.984 0.984   10% 0.991 0.991 0.991 
 15% 0.982 0.984 0.984   15% 0.991 0.991 0.991 
 20% 0.981 0.983 0.983   20% 0.992 0.991 0.991 
 30% 0.981 0.982 0.982   30% 0.991 0.991 0.991 
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Chapter 4  
Detecting Contamination in RNA Sequencing Experiments 
Abstract   
Until recently, microarrays were the standard way to collect data about differences in 
gene expression between individuals. However, microarrays can only target specific regions in 
known transcripts, giving only a partial view of gene expression. The next evolution of gene 
expression data collection is RNA-Seq, which enables genome-wide studies of both known and 
novel transcripts. By converting mRNA to cDNA, we can leverage the speed and accuracy of 
DNA sequencing machines to collect lots of data without much effort. However, as with any 
genetic data, the possibility exists for a sample to become contaminated with the RNA of a 
different individual. Here we propose a likelihood based model to detect and quantify inter-
sample RNA contamination using data already generated by the sequencer without requiring an 
additional experiment. Our method produces estimates with an average error of 0.5% for 
contamination levels from 2%-10%.  
Introduction 
Just as high-throughput sequencing technologies have revolutionized the collecting of 
sequence information from genomic DNA, these technologies have created new opportunities 
to investigate gene expression. RNA-Seq is a method by which RNA is captured from a cell, 
converted to cDNA, and undergoes sequencing on a sequencing machine1. Typical high-
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throughput pipelines produce tens of millions of short reads (35-100bp) from the collection of 
cDNA fragments. Then an aligner or assembler determines the most likely genomic positions 
from which the fragments originated2. Once fragments are placed, tools are available to 
compare the relative number of observed transcripts for each gene to understand which genes 
are being expressed and at what abundance. 
While current sequencing machines are capable of quickly producing vast amounts of 
sequencing data with few read errors, there is still a need to thoroughly check the quality of the 
data prior to analysis. For example, samples sequenced at different times or with different 
library preparations often have batch effect differences4. Differences in gene transcript 
abundance may simply be due to technical artifacts from library preparation or RNA capture 
rather than true expression differences. Failure to account for these differences may result in 
false positive associations or reduced power. Proper quality control is an important step in a 
RNA-Seq processing pipeline. 
One important quality control measure for all NGS data is a screen for sample 
contamination. We previously developed methods to identify and quantify contamination in 
DNA sequencing studies in which DNA from two or more individuals are present in a single 
sample3. This method has been used to detect contamination in many large sequencing studies 
and is recommended as a standard test during DNA sequence quality control5,6. 
There are three basic types of within-species contamination that may occur in RNA-Seq 
studies: 1) intra-sample DNA-RNA contamination, 2) intra-samples RNA-RNA contamination, 
and 3) inter-sample RNA contamination. Intra-sample DNA-RNA contamination occurs when 
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not all the genomic DNA is removed from the cDNA prior to sequencing. This sort of 
contamination manifests as reads mapping to intergenic regions and thus can be identified 
during read alignment. Intra-samples RNA-RNA contamination occurs when different tissue 
types from a single individual are sequenced together. In this case, the observed reads will not 
have genotype differences between tissues, but they may potentially have expression 
differences. Unfortunately most tissues are likely a mixture of cell types which makes resolving 
the source of each RNA fragment difficult. Since differences between cell types are more subtle 
because transcripts across tissues are likely to have identical genotypes, we will not attempt to 
model this type of contamination.  In this paper we focus on the problem of inter-sample RNA 
contamination whereby the RNA from two different samples are sequenced together as one. 
While the data produced by RNA-Seq and genomic DNA sequencing are similar, there 
are two characteristics of RNA-Seq data that could require more complex modeling for accurate 
contamination estimation than DNA sequencing data. First is gene expression variability. For 
DNA contamination detection, we may reasonably assume that samples contribute sequence 
reads in proportion to the contamination level at each genomic position. For RNA-Seq, the two 
samples may be expressing genes at different levels. In the most extreme case, an intended 
sample does not express a gene but the contaminating sample does, so that all the reads for 
this gene would come from the contaminating sample and on its own may not appear 
contaminated. Second is allele specific expression (ASE). In contrast to DNA sequencing in 
which we expect either allele at a heterozygous site is equally likely observed, ASE alters that 
expectation by preferentially transcribing from the DNA strand with a particular allele. The 
deviation from balanced chromosomal expression depends on the strength of ASE for the 
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particular gene. It has been suggested that ASE may occur for ~20% of human genes7. We are 
interested what effects these phenomena may have on the estimation of contamination for 
RNA-Seq data. 
Materials and Methods 
Here we provide a statistical model to detect contamination in RNA-Seq data and 
describe the experimental datasets used for its validation. 
We begin by making a few simplifying assumptions about RNA-Seq data in order to 
model contamination. First we assume a list of known variant sites within transcripts with 
known allele frequencies. Second we assume all reads are independent and all observed bases 
at a particular site are independent. Third we assume that either allele is equally likely to be 
observed at a heterozygous site; thus this model does not explicitly model deviations as the 
result of ASE. Fourth we assume that when base read errors occur, all three other bases are 
equally likely observed. Finally, this formulation assumes gene expression is consistent across 
individuals. 
Following our previous work for DNA sequence contamination3, we model RNA sample 
contamination with a mixture model. Let 𝑔𝑖
(1)
 and 𝑔𝑖
(2)
 be the genotypes for the intended and 
contaminating samples at variant site 𝑖 (1 ≤ 𝑖 ≤ 𝑀), 𝑏𝑖𝑗 be the observed base at position 𝑖 for 
read 𝑗 (1 ≤ 𝑗 ≤ 𝑅𝑖), 𝑒𝑖𝑗 a latent variable indicating whether a base calling error occurred (𝑒𝑖𝑗 =
1) or did not (𝑒𝑖𝑗 = 0), and 𝛼 the proportion of reads from the contaminating sample. 
We model the probability of observing a particular base 𝑏𝑖𝑗 as 
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𝑃(𝑏𝑖𝑗|𝑔𝑖
(1)
,  𝑔𝑖
(2)
; 𝛼) = (1 − 𝛼)𝑃(𝑏𝑖𝑗|𝑔𝑖
(1)
) + 𝛼𝑃(𝑏𝑖𝑗|𝑔𝑖
(2)) 
where 
𝑃(𝑏𝑖𝑗|𝑔𝑖) = 𝑃(𝑏𝑖𝑗|𝑔𝑖,  𝑒𝑖𝑗 = 1) 𝑃(𝑒𝑖𝑗 = 1) + 𝑃(𝑏𝑖𝑗|𝑔𝑖,  𝑒𝑖𝑗 = 0) 𝑃( 𝑒𝑖𝑗 = 0) 
We present the read probabilities allowing for error 𝑃(𝑏𝑖𝑗|𝑔𝑖,  𝑒𝑖𝑗) in Table 1. We estimate the 
probability of a read error as 𝑃(𝑒𝑖𝑗 = 1) = 10
−𝑄𝑖𝑗/10 and 𝑃(𝑒𝑖𝑗 = 0) = 1 − 𝑃(𝑒𝑖𝑗 = 1), where  
𝑄𝑖𝑗  is the phred-scaled base quality score for the RNA sequence data
8. To estimate the 
genotype probability 𝑃(𝑔𝑖), we use allele frequencies from the population from which the 
sample was drawn and assume Hardy-Weinberg equilibrium.  
Taking expectations over the unknown genotypes and assuming all reads and loci are 
independent, we write the likelihood for contamination level 𝛼 in an individual sample as  
𝐿(𝛼) = 𝑃(𝐵|𝛼) = ∏ ∑ ∑ {𝑃(𝑔𝑖
(1)
)𝑃(𝑔𝑖
(2)
) ∏ [(1 − 𝛼)𝑃(𝑏𝑖𝑗|𝑔𝑖
(1)
) + 𝛼𝑃(𝑏𝑖𝑗|𝑔𝑖
(2)
)]
𝑅𝑖
𝑗=1
}
𝑔
𝑖
(2)
𝑔
𝑖
(1)
𝑀
𝑖=1
 
For each sample, we first maximize 𝐿(𝛼) using a grid search in the interval 0.0 ≤  ≤ 0.5 and 
then apply Brent’s algorithm9 to obtain the maximum likelihood estimate of α. By using 
information across a large number of variants 𝑀, we determine if the observed reads are better 
explained by a single sample or a combination of two samples with mixing proportion 0 <  𝛼 <
1 .  
To validate this method, we constructed contaminated samples in-silico using publically 
available data from the GEUVADIS project10. We used RNA-Seq data for 452 samples drawn 
from the 1000 Genomes Project11 from 5 different populations: Utah residents with Northern 
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and Western European ancestry (CEU), Finns in Finland (FIN), British in England and Scotland 
(GBR), Tuscans in Italy (TSI), and Yoruba in Ibadan, Nigeria (YRI). The RNA for each sample was 
extracted from lymphoblastoid cell lines. These samples also had Illumina HumanOmni2.5 array 
genotypes available from the 1000 Genomes Project. We only used samples that had estimated 
levels of RNA contamination <1% (dropped 8 samples). We combined reads from pairs of 
samples within populations adjusting for differences in overall read depth to simulate 
contamination levels from 2%-30%. We then estimated contamination using (subsets of) variant 
sites from the HumanOmni2.5 genotype array. 
To evaluate performance in real-world setting, we estimated contamination using 185 
samples with RNA-Seq data from an ongoing psoriasis skin RNA-Seq project. Samples were 
sequenced on an Illumina Genome Analyzer IIx with a read length of 80bp. Alignment was 
performed with BWA12 against the NCBI build 37 human reference genome. Samples had 
genotype array data for the Illumina HumanExome chip which allowed us to verify identity. 
In all analyses, we estimated contamination using our cleanCall software13. We 
increased the default setting for DNA studies for the maximum number of reads from 20 to 500 
to better accommodate the larger read depth from RNA-Seq data. We used population allele 
frequency estimates specific to each population calculated from the HumanOmni2.5 genotype 
array data. 
Results 
When estimating contamination with DNA data, we used sites across the entire 
genome, but for RNA-Seq we observed more accurate results when using sites in exons. While 
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it is often possible to observe reads outside exons due to non-coding or novel transcripts, we 
focus on exons to avoid the impact of alignment errors enriched in the reads mapped outside 
the exome. We estimated contamination from the constructed samples (1) using a random set 
of sites genome-wide from the HumanOmni2.5 genotype array and (2) using a set of sites 
annotated as being in a gene exon by GENCODE14 to compare estimates based on the genome 
and exome. We limited both sets of sites to roughly 100,000 so any differences were not based 
on simply using a different number of sites. We found that results using sites from all over the 
genome ignoring exonic annotation produced less accurate estimates of contamination 
compared to using sites in the exome (Figure 1). For example, when 𝛼 = 15%, the mean 
absolute difference in the estimated ?̂? and intended 𝛼 was 0.9% for the exonic sites and 1.3% 
for genomic sites. The average absolute difference between the estimated and intended 𝛼 was 
less than 0.5% for the exonic sites for 2% ≤  𝛼 < 20%. For 𝛼 ≥ 20%, both sets 
underestimated 𝛼 on average, but the exonic sites were more accurate. Furthermore, the 
standard deviation from the genomic estimates was >1.6x compared to exomic estimates under 
all experimental settings. Much of the difference can be explained by the smaller number of 
reads present at the off-target sites. 
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Figure 4-1- Estimating Contamination Using Exonic vs Genomic Sites. We plot the distribution 
of (?̂? − 𝛼)100 from our experimentally constructed contaminated samples. We compare 
estimates using sites exclusively from the exome to sites from across the genome. “Avg DP” is 
the average depth (# reads) per variant site.   
 
Excluding sites inside exons of genes with the highest expression variation among 
samples did not meaningfully change our contamination estimates. We believed that by 
dropping the most variably expressed genes, we could reduce some of the noise in the 
estimation and obtain more precise estimates however we did not observe a practical 
difference. To test this we used the data provided by the GEUVADIS project which estimated 
the reads per kilobase of transcript per million mapped reads (RPKM). We then calculated the 
coefficient of variation (standard deviation/mean) for the RPKM values for each site across all 
samples and removed the sites from those genes in the >90 percentile and those in the >50 
percentile. The total number of sites used for estimation was ~100,000 for all exonic sites 
compared to ~95,000 and ~80,000 for the <90 and <50 percentile sites respectively. We 
observed that estimates that avoided the most variable genes were highly concordant with the 
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original estimates (Figure 2). The Pearson correlation of estimates from all exome sites 
was >0.999 for both the <50 and <90 percentile sites. We concluded that individual expression 
differences was not interfering with our ability to estimate contamination in a meaningful way. 
 
Figure 4-2- Estimates of Contamination Ignoring Most Variable Genes We plot the distribution 
of (?̂? − 𝛼)100 from our experimentally constructed contaminated samples. We compare 
estimates using all genes, excluding the >90% most variable genes, and excluding the >50% 
most variable genes. “Avg DP” is the average depth (# reads) per variant site.   
 
Figure 4-3 - Contamination Estimation Dropping Sites with Evidence for ASE. We plot the 
distribution of (?̂? − 𝛼)100 from our experimentally constructed contaminated samples. We 
compare estimates using all sites, sites with no significant evidence of ASE at the p<.005 level, 
and sites with no significant evidence of ASE at the p<.05 level. . “Avg DP” is the average depth 
(# reads) per variant site.   
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To investigate the impact of allele specific expression estimates, we excluded sites that 
showed evidence of ASE in any of the samples. We used the estimates of ASE provided by the 
GEUVADIS project and collected lists of sites where at least one individual had evidence for ASE 
at either the p=.005 or p=.05 level, which left ~77,500 and ~67,000 sites per individual 
compared to ~100,000 using all exonic sites. Estimating contamination using sites with no 
evidence for ASE leads to deflation of the contamination estimate and increased variance >1.4x 
for all levels of contamination (Figure 3). The difference is primarily driven by the reduction in 
summed read depth for all included sites; when we exclude sites with significant evidence for 
ASE, we exclude sites with greater read depth. More reads result in an increased power to 
detect expression differences and can generate more significant p-values. 
When we applied our method to data from the psoriasis sequencing project, we 
identified a set of samples that had been incorrectly labeled during sequencing. We found 21 
samples with estimated levels of contamination ?̂?>90% when using the existing genotype array 
data (Figure 4). By comparing the read data to the original genotype data, it was possible to 
correct the labels for 19 of the 21 samples. An additional 6 samples showed contamination 
between 20% and 90%. We recommend that these samples should be dropped from analyses 
that intend to make inference at the individual level since reads cannot be easily assigned to a 
particular sample. 
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Figure 4-4 - Contamination Estimates from Psoraisis Data. Each point is the value of ?̂? for a 
sample using available genotype array data, sorted along the x-axis by ?̂?. 
Discussion 
We have shown that modeling contamination in RNA-Seq data the same way that we do 
with DNA sequencing data can work very well if we focus on variant sites in the exome. On 
average the difference between ?̂? and the true 𝛼 was less than 0.5% for contamination levels 
up to 10%. We have also shown that this method can be combined with genotype array data to 
identify mislabeled samples. 
In our analyses, we assumed the true sample population allele frequencies for each of 
the variant sites were known; however, this information may not always be available if you are 
studying a population that has not previously been characterized. Probably the best alternative 
would be to use frequency estimates calculated from genotype array data for the same or 
similar samples. Alternatively, the allele frequencies can be estimated using the proportion of 
reads that carry each allele across multiple sequenced samples. Finally, one could use allele 
frequencies from a closely related HapMap or 1000 Genomes Project population. It is important 
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that the frequencies accurately represent your samples. As with DNA data, misspecification of 
these frequencies often leads to underestimates of 𝛼3. 
Our model assumes that all sites are independent; this is not generally true for real data. 
For example, some nearby sites are correlated due to linkage disequilibrium (LD). The data for 
the experiments above used all sites in the exome from the HumanOmni2.5 genotypes array. 
We also did the experiment after pruning the sites based on LD estimates from the genotype 
array data. We pruned sites such that no pair in a 50 site-wide, 5 site-sliding window had an 𝑟2 
value greater than 0.2, leaving ~40,000 of ~100,000 sites. The correlation between the ?̂? values 
for the full exome list and the LD-pruned exome list was 𝑟2 > 0.996, demonstrating the impact 
on estimation from correlated sites was modest.  
Alternative gene splicing can make it hard to align reads to a reference, especially at 
splice junctions at the ends of exons. Splicing results in different sets of exons being merged 
together into the final RNA message before translation into a protein. This means that 
sequencing reads at the beginning or ends of exons are more difficult to correctly align because 
of the uncertainty of the surrounding sequence. We tested if this may have any significant 
impact on contamination estimation by excluding variant sites located with 10 base pairs of 
splice sites. This resulted in site list with ~6,000 fewer variants. This filtering produced nearly 
identical estimates of contamination (r2>0.999) across all simulation settings. 
Ultimately we decided not to directly model expression variability or ASE because our 
estimates ignoring the phenomena were accurate and the experiments where we dropped 
potentially troublesome sites did not appear to improve the precision or reduce the variability 
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of the estimates. The power of this mixture model is that information is combined across a 
large number of sites so it is difficult for local deviations from the model expectations to 
overpower the contamination signal. Modeling ASE would most easily be done in a Bayesian 
framework where we could put a prior distribution on the probability of observing alleles at 
heterozygous sites rather than assuming it is always 0.5. However, our results suggest the 
simpler model presented here is entirely sufficient for its purpose. 
In summary, we have demonstrated the usefulness of this mixture-model-based method 
to easily and quickly detect contamination in RNA-Seq data after reads have been aligned. We 
suggest screening all RNA-Seq data to check for any potential quality problems. Samples may be 
excluded from a study depending on the level of tolerance for measurement error of the 
downstream analysis. 
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Chapter 5  
Summary 
 
There is no more important lesson that I have learned in my training as a biostatistician 
than this: real data are messy. Messiness comes in many forms: missing observations, surprising 
outliers, unusual patterns, etc. This messiness often interferes with the direct application and 
interpretations of standard statistical methods because of possible assumption violations. We 
can choose to view messy data as something that interferes with “real” statistics, or we can 
embrace the irregularities of experimental data and use that to motivate a deeper statistical 
investigation into of realities of the data. Messy data should make a statistician excited, rather 
than deterred – it simply means there are lessons to be learned. Those lessons might be that 
the way of collecting data has errors or can be improved, or that the data has properties we do 
not yet understand. 
This work on contamination was not motivated by a scientific curiosity to intentionally 
mix samples together; rather it was in response to unusual patterns in our observed data and a 
strong desire to understand the causes. Contamination was just a hypothesis we had about 
what might cause those patterns. We then thought about new ways to look at the data and 
looked for simple statistical models we might be able to use to test this hypothesis. In the end, 
we developed a new set of tools that made it possible to detect and quantify contamination for 
a wide variety of genetic data. 
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In the case of detecting contamination in genotype array data, we were able to use data 
already generated by the genotyping instrument in a novel way to test this new hypothesis. Our 
methods look at the probe intensity data which is normally just used to call genotypes. By 
combining this data with population allele frequencies in a regression model or using this data 
in multivariate normal mixture model, we can test for contamination without having to run a 
separate experiment. Our method runs quickly enough to be able to screen large numbers of 
samples efficiently and can integrate nicely into a standard quality control pipeline for genotype 
array data. 
We learned that contamination usually does not have a large impact on genotype 
concordance for genotype array data. We compared the concordance for samples in Chapter 2 
that were contaminated in-vitro at known mixture proportions against their uncontaminated 
counterparts. Even at 10% contamination, genotype calls were >.999 concordant (Figure 5-1). 
The only noticeable effect is an increase in the number of missing genotypes. Rather than make 
an incorrect genotype call, the Illumina software is much more likely to simply not make a call 
for that variant. Dropping samples with low call-rates has for a long time been a standard 
quality control filter prior. With the development of these methods to detect contamination, 
we now can offer a possible answer to why the sample had a low call rate which was not always 
clear previously. 
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Figure 5-1 - Effects of Contamination on Genotype Array Calls - The left panel shows genotype 
concordance for each of the contaminated mixtures with the uncontaminated sample. The right 
panel shows the increase in the number of missing genotypes for each contaminated mixture 
compared to the uncontaminated sample. 
Even though contamination does not have a large effect on genotype accuracy for array 
data, the shifts in intensity from contaminated data are still capable of detecting low-levels 
contamination (2-10%). Since genotype arrays are so much cheaper than DNA sequencing, 
running data on a genotype array prior to sequencing can be a cost effective way to screen 
samples prior to sequencing. We saw in Chapter 3 that low levels of contamination have a 
much greater impact on genotype concordance for sequencing data compared to array data. 
There is some uncertainty when a sample is identified as contaminated as to when the 
contamination occurred. It could have happened during preparation for genotyping or it could 
have happened at the time of collection. If samples are repeatedly tested, it can be possible to 
determine if the original sample is bad or if something went wrong during genotyping 
depending on the consistency of the contamination estimate. 
While genotype arrays were the go-to source of genetic data for association studies 
when I first started my studies of statistical genetics, we have clearly started to transition to the 
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age of sequencing. We are now able to investigate nearly every position in the genome rather 
than a few select sites. The technology driving this revolution continues to get cheaper, faster, 
and more accurate; however the problems of contamination have also made their way to this 
technology. 
One additional challenge of working with DNA sequencing data is batch effects. 
Sequencers may produce systematic differences in the read data for samples depending on 
when and where they are processed. Ideally, all samples would be sequenced at the same place 
and time with cases mixed with controls; however this is not always possible. We were 
reminded of this problem when we created contaminated samples for Chapter 3. When we 
combined the exome sequencing data and estimated contamination, we observed an odd 
bimodal distribution of estimates (Figure 5-2A). Further investigation revealed that the samples 
were sequenced at different sequencing centers. If we stratified our analysis by the sequencing 
center for each of the samples in the contaminated pair, we can see that the distribution of 
estimates is much closer to expectation (Figure 5-2B). 
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It is very useful to view the estimates of contamination in a context that is aware of the 
experimental conditions under which the samples were created. For example, most of our 
samples are processed in set of 96-well plates. If we plot our estimate of contamination in a 
way that reflect the plate and position where a sample came from, we can learn about how 
contamination may have occurred. An example of this type of plot is given in Figure 5-3. We can 
see that problems might only affect certain plates and positions rather than indicate a more 
wide spread problem. 
Figure 5-2 - Contamination Estimates from Different Sequencing Centers - (A) the distribution 
of ?̂? for all exome sequencing samples contaminated at 30%. (B) the distribution of ?̂? 
conditioned on the sequencing centers for each of the samples in the contaminating pair. 
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 Our test for DNA contamination can happen just after the sequence reads are aligned. 
Previously the effects of contamination typically were not seen until sample genotypes were 
called. Contaminated samples would have many more heterozygous sites than expected. 
Genotype calling can be a time consuming process and is normally delayed until a large number 
of samples are collected. Our method allows for much earlier detection of contamination, 
possibly allowing time for changes in a protocol or pipeline to correct any errors before all 
samples are sequenced. To be even more responsive, these methods could be adapted to 
collect observed bases from fastQ files prior to alignment. If you know the flanking sequencing 
Figure 5-3 – Contamination Estimates in 96-Well Plate - The color of each 
square represents the genotype-free estimate of contamination and the 
color inside the circle represents the estimate using genotype data. Sample 
swaps are indicated in yellow. 
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around variant sites, you can find relevant reads for those sites without aligning every read. 
This will save further time because alignment is also a time-consuming process. 
 While we have worked out a clear method for correcting contaminated DNA samples, 
the method of correction for RNA-Seq data is not so clear. Currently there is no standard 
analysis of RNA-Seq data similar to the way DNA sequencing is used for genotyping. Further 
work is required to understand the impact of contamination on the various RNA pipelines and 
different corrections may be appropriate for different analyses. 
 As the manufactures of sequencing machines continue to innovate and new assays are 
developed, the data we receive from sequencing machines may change. The methods 
described here have been tested and validated with current generation sequencing machines. It 
will surely be necessary to adapt these methods in the future for different instruments and 
protocols because while technology may improve, it is likely that contamination will continue to 
be a potential problem for genetics studies. 
 Up until now we have focused on contamination as an important quality control step, 
however there are natural biological phenomena where some form of “contamination” is 
expected. Two such examples are genetic chimerism and cell-free fetal DNA. In the case of 
genetic chimerism, an embryo develops with two or more distinct cell lines when multiple 
fertilized eggs merge. This means that two cells from the same individual may have distinct DNA 
sequences. Since both fertilized eggs presumably arose from the same set of parents, there 
would be a high degree of similarity between the sequences. If we estimated contamination in 
different windows across the genome, we expect to find ?̂? > 0 for regions where different 
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cross-over events occurred during meiosis. Cell-free fetal DNA is the phenomenon where DNA 
from a fetus can be found in the blood of his pregnant mother. This may also look like 
contamination since the DNA sequences of two individuals would be sequenced as one. But as 
with chimerism, we expect a high degree of similarity given that the samples are genetically 
related. 
 So whether our interests in mixtures of DNA are motivated by genetic hypothesis of 
natural phenomena or a test for quality from a complicated laboratory protocol, the methods 
we have outlined here will help with the understanding and interpretation of high-throughput 
genetic data for years to come. 
